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Abstract 
 
Contrasting physiological requirements for T. brucei survival between procyclic 
(vector) and bloodstream (mammal) forms necessitate different molecular processes and 
therefore changes in protein expression. Transcriptional regulation is unusual in T. 
brucei because the arrangement of genes is polycistronic; however, genes which are 
transcribed together are subsequently cleaved into separate mRNAs by trans-splicing 
and are individually regulated. During the process of trans-splicing, a 39-nucleotide 
splice-leader RNA is added to the 5´ end of mRNA. In this study, gene regulation in 
trypanosomes will be examined in the context of the 7-methylguanosine cap attached to 
the 5´ end of the splice-leader. Interestingly, in addition to the capping enzymes 
identified in other eukaryotes, trypanosomatids have an additional guanylyltransferase 
and methyltransferase in the form of a bifunctional enzyme (TbCGM1).TbCGM1 was 
found to be essential in bloodstream form T. brucei, althoughthe purpose of this 
bifunctional capping enzyme remains unclear. Null mutants of a related enzyme, 
monomeric methyltransferase TbCMT1, did not show an effect on cell viability in 
culture, however, the enzyme proved to be important for virulence in vivo. 
Complementary to the study of T. brucei capping enzymes, we worked to develop a 
method to allow structural analysis of the 5´mRNA cap by mass spectrometry.   
Following pre-mRNA processing, regulation of the mature mRNAs is a tightly 
controlled cellular process. While multiple stage-specific transcripts have been 
identified, previous studies using RNA-seq found that the changes in overall transcript 
level do not necessarily reflect the abundance of the corresponding proteins. We 
hypothesized that in addition to mRNA stability, mRNA recruitment to ribosomes may 
play a significant role in the regulation of gene expression in T. brucei. To approach this 
xiii 
 
question, we performed RNA-seqof total, subpolysomal, and polysomal mRNA.This 
transcriptomic data was then correlated with published proteomic studies to obtain a 
global picture of the relative translation efficiencies and their relationship to steady-state 
protein levels between bloodstream and procyclic form T. brucei. 
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INTRODUCTION 
1.1 Human African Trypanosomiasis 
Trypanosoma brucei, the protozoan parasite transmitted by the tsetse fly, causes Human 
African Trypanosomiasis (HAT) and Nagana in cattle. Following the observations of 
flagellated parasites (now called trypanosomes) in the blood of frogs and small rodents, 
in the late nineteenth century, Sir David Bruce discovered the subspecies of 
trypanosomes (Trypanosoma brucei brucei) associated with Nagana which lead to the 
understanding of the parasite’s life cycle and eventual discovery of human infective 
trypanosomes by R. M. Forde and J.E. Dutton who named them Trypanosoma 
gambiense(Dutton, 1902; Forde, 1902). In 1910, J. W. W. Stevens and H. B. Fantham 
described a distinctive subspecies of human trypanosome they named Trypanosoma 
rhodesiense(Stephens and Fantham, 1910). It is now known that Trypanosoma 
rhodesiense causes an acute form of HAT in East Africa and Trypanosoma gambiense 
causes the chronic form of the disease in Western and Central Africa (WHO, 2014). Sir 
David Bruce also pioneered the studies that identified the tsetse fly as the transmission 
vector (Cox, 2004). HAT, commonly referred to as sleeping sickness, infection 
manifests itself in two phases: the first stage during which the trypanosomes proliferate 
in the blood of the host, followed by the second stage when the parasites cross the 
blood-brain barrier and invade the central nervous system. This second stage is 
characterized by neurological disorders and is, with rare exception, fatal if left untreated 
(MacLean et al., 2012; Stuart et al., 2008).  
The World Health Organization (WHO) hasled a campaign to eliminate HAT bringing 
together an alliance of international institutions, organizations and pharmaceutical 
companies (Simarro et al., 2012). Because sleeping sickness affects poor rural 
populations that lack access to adequate health facilities, treatment is an even bigger 
burden (Simarro et al., 2011). The cooperative effort has succeeded in increasing the 
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control and surveillance of the at-risk populations and as a result,  reducing the number 
of new cases each year by 82%, with only 6,228 new cases reported in 2013 although 
millions of people are still at risk (Franco et al., 2014; Simarro et al., 2012). Recently, 
the widespread use of nifurtimox-eflornithine combination therapy (NECT)has been a 
great advancement in the treatment of HAT with high efficacy, lower toxicity, and 
shorter course of treatment than previous medication (Alirol et al., 2013; Franco et al., 
2012; Priotto et al., 2009; Yun et al., 2010). However, NECT still involves a regimen of 
invasive procedures that are difficult to administer in regions of poor health 
infrastructure creating a need for the development of oral drugs that target the second 
stage of the disease (Barrett et al. 2007).  
1.2 The life cycle of T. brucei 
When a Tsetse fly feeds on infected blood from a human or animal, it is infected by 
stumpy form T. bruceitrypomastigotes which differentiate into the proliferating 
procyclic form in the fly midgut(Sbicego et al., 1999). From the midgut, the PCF 
trypanosomes progress through the salivary gland as epimastigotes and then further 
differentiate into infective metacyclics(Van Den Abbeele et al., 1999). During a 
subsequent blood meal, the Tsetse fly transmits the metacyclictrypomastigotes into the 
haemolymphatic system of the host where they transform into the rapidly proliferating 
bloodstream slender form, and the cycle begins again (Figure 1.1).  
Bloodstream form T. brucei are coated by approximately 5 million variant surface 
glycoprotein (VSG) homodimers that form a dense monolayer and are attached to the 
cell surface via a GPI anchor (Cross, 1975; Ferguson et al., 1988). These glycoproteins 
give the parasite a mechanism of immune system evasion.  
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Although VSGs stimulate an immune response in the host which clears most of the 
infection, a small proportion of the remaining parasites switch their surface coat to a 
different VSG and repopulate in the bloodstream of the host (Cross, 1979; Horn and 
Cross, 1997; Pays and Nolan, 1998). This process of VSG switching and the consequent 
waves of parasitemia are known as antigenic variation (Doyle et al., 1980).   
1.3 The T. brucei nuclear genome 
The nuclear genome of T. brucei contains 11 megabase-sized chromosomes, ~5 
intermediate-sized chromosomes, and ~100 minichromosomes(Berriman et al., 2005; 
Melville et al., 2000). Unlike other eukaryotic genomes, the genomes of kinetoplastids 
(T. brucei, T. cruziand Leishmania) share an unusual genomic architecture where 
adjacent genes form long, non-overlapping transcription units (Figure 1.2). These gene 
clusters contain between approximately tens to hundreds of protein coding sequences in 
Figure 1.1: T. brucei life cycle. Image adopted from www.cdc.gov.  
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the same transcriptional orientation (Berriman et al., 2005). Another difference of 
trypanosomatid genomic arrangement is that the majority of protein coding genes do not 
have introns. The exceptions are a poly(A) polymerase and an ATP-dependent DEAD 
box RNA helicase which each have one intron that is removed by cis-splicing (Mair et 
al., 2000a; Preußer et al., 2014). 
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1.4 Polycistronic transcription and trans-splicing in T. brucei 
Transcription is particularly interesting in T. brucei because the arrangement of its 
genes is polycistronic. RNA Polymerase II (RNA Pol II) transcribes protein-coding 
genes into large polycistrons containing several transcripts, however, the polycistron 
Figure 1.2: Genomic organization in T. brucei according to the transcribing 
polymerase. Bars above the chromosome backbone (black) indicate transcription 
toward the right; bars below the line indicate transcription toward the left. Similar 
elements close together in the genomeare indicated by n× (where n is the number of 
elements). Adopted from (Daniels et al., 2010). 
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does not linger as it is co-transcriptionally processed into individual mRNAs(Johnson et 
al., 1987; Mottram et al., 1989). These polycistrons are unidirectional and partitioned by 
strand-switch regions (SSRs) between stretches of genes that are characterized by a 
stretch of G nucleotides (Figure 1.3). Polycistronic transcription was discovered by in 
vitro run-on transcription assays investigating the mechanism of the transcription of the 
tubulin gene locus in T. brucei(Imboden et al., 1987). It was found that although 
intergenic regions between tubulin genes were transcribed at the same rate as the genes 
themselves, transcripts containing intergenic regions could not be detected leading to 
the conclusion that the transcription of the tubulin gene cluster proceeds as a single 
contiguous primary transcript which is then rapidly processed into individual mRNAs 
(Imboden et al., 1987). The processing of the transcription unit occurs co-
transcriptionally by trans-splicing coupled to cleavage of the 3´ end by the 
polyadenylation machinery for poly(A) addition (Huang and van der Ploeg, 1991; Ullu 
et al., 1993). 
 During trans-splicing, a capped 39-nucleotide (nt) spliced leader (SL) mini-exon is 
added to the 5′ termini of mRNAs. The SL sequence was first discovered when two 
different VSG transcripts were found with an identical leader sequence at their 5′ ends, 
which was not evident in their genomic sequence (Boothroyd and Cross, 1982; Parsons 
et al., 1984; Van der Ploeg et al., 1982). This mini-exon is independently transcribed 
from a tandem array of 140-nt spliced leader (SL) RNA genes (Figure 1.3) (Gilinger 
and Bellofatto, 2001; Sather and Agabian, 1985).  
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Figure 1.3: mRNA processing in T. brucei. Schematic of a hypothetical chromosome 
with three polycistronic gene clusters (PGC1-3). RNA Polymerase II (RNA Pol II) 
transcription initiates upstream of the first gene of the PGC (arrows). The stretch of 
G nucleotides present at strand-switch regions (SSR) is indicated. Transcription of a 
PGC is processed by trans-splicing and polyadenylation to generate the mature 
mRNAs (shown only for PGC2). In the SL RNA locus, each SL RNA (yellow box) 
possesses an RNA Pol II promoter region (arrows). The 5’ cap is indicated by an 
asterisk. The pyrimidine-rich regions (shown asgreen-striped boxes in the intergenic 
regions) are needed for both trans-splicing and polyadenylation. Adapted from 
(Martínez-Calvillo et al., 2010). 
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The mechanism of trans-splicing is a two-step transesterification (Figure 1.4). In the 
first transesterification step, there is a nucleophilic attack by the 2′OH of the branch 
point (BP) adenosine from the pre-mRNA onto the 5′ splice site (SS) of the SL RNA. 
This generates the SL mini-exon intermediate and the SL intron/protein-coding exon 
‘Y-structure’ formation (Murphy et al., 1986). In the second step, the free -OH of the 
SL mini-exon attaches to the 3′ splice site (SS) of the protein-coding exon. The product 
of these reactions is the first 39 nucleotides (mini-exon) of the SL RNA precursor and 
the protein-coding exon are joined together, yielding an mRNA that is ready for 
polyadenylation (Agabian, 1990; Laird et al., 1987; Sutton and Boothroyd, 1986).  
1.5 Structure and function of the T. brucei hypermethylated cap4 
In addition to acting as a splicing substrate for the excision of an mRNA from the 
primary transcript, the SL RNA also provides each protein-coding mRNA with the cap 
structure through trans-splicing. For all cells in which it has been investigated, the 
structure of the mRNA 5´cap was determined to be 7-methylguanosine (Furuichi et al., 
1977; Rottman et al., 1974; Shatkin, 1976). Trypanosomatids contain a unique structure 
at the 5´end of all mRNAs called cap4 (Freistadt et al., 1987, 1988; Perry et al., 1987). 
The cap4 structure is hypermethylated and consists of a conserved m
7
G cap followed by 
four nucleotides with 2′-O-ribose methylations as well as additional base methylations 
on the first and fourth nucleotides: (m
7
G(5´)ppp(5´)m
6
2AmpAmpCmpm
3
Ump) (Figure 
1.5) (Bangs et al., 1992; Sutton and Boothroyd, 1988). The remarkable discovery of the 
trimethyladenosine and the dimethyluridine hypermethylated nucleotides in the cap4 
structure were previously unknown in nature (Bangs et al., 1992). Although the 
complex cap4 structure of the SL RNA is a prerequisite for trans-splicing and is 
therefore essential for the production of mature mRNAs, the mechanism remains 
unclear (McNally and Agabian, 1992; Ullu and Tschudi, 1991).  
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Figure 1.4: Mechanism of trans-splicing in T. brucei. The SL RNA and a pre-mRNA 
are pictured, outlining the conserved branch point (BP) adenosine (A), the 
polypyrimidine tract (Py), a single protein-coding exonof a longer polycistronic 
transcript (blue box), the SL mini-exon (red box), and the 5’cap (        ). The 
consensus sequences directly adjacent to the 5′ and 3′ splice sites (5′SS; 3′SS) are 
also shown. Adapted from (Liang et al., 2003). 
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Binding an antisense oligonucleotide to nt 7-18 of the SL sequence, and therein 
preventing modification of the cap4, disabled the use of the SL RNA in trans-splicing 
(Ullu and Tschudi, 1993). That study further supported the importance of the cap4 
structure for the fidelity of translation competent mRNA. Modification of the cap 
structure is not limited to T. brucei as the trypanosomatid protozoa contain common 
machinery for co-transcriptional cap4 formation (Mair et al., 2000b; Ullu and Tschudi, 
1995).  
 
Figure 1.5: Trypanosomatid cap4 structure. Them7G cap is methylated at the N7 
position (red). There are also 2-O ribose methylations on the first four nucleotides 
(orange) as well as base methylations on the first adenosine and uridine (green) of 
the SL RNA. Adopted from (Bangs et al., 1992; Zinoviev and Shapira, 2012) 
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1.6 T. brucei capping enzymes 
The importance of the modification at the 5´ end of T. brucei SL RNA lead to the 
characterization of the enzymes involved in this process.Cap formation occurs in three 
enzymatic reactions. First, the 5´ triphosphate end is hydrolysed by a triphosphatase to 
produce diphosphate–RNA. Next, the guanylyltransferase catalyses the addition of 
GMP to the diphosphate–RNA to produce the guanosine cap. Finally, the cap is acted 
upon by a guanine-7-methyltransferase, catalysing the methylation of the guanosine cap 
at the N-7 position. The capping system in metazoans and plants consists of a 
bifunctional triphosphatase- guanylyltransferase and a separate methyltransferase 
(Figure 1.6) (Cowling, 2010; Shuman, 2001, 2002). In T.brucei, the first characterized 
enzyme of the capping machinery was the mono-functional guanylyltransferase 
(TbCE1), which transfers GMP to the diphosphate end of RNA. There was no 
noticeable effect on PCF T.brucei cell viability when this activity was down-regulated 
by RNAi(Ruan et al., 2007; Silva et al., 1998; Takagi et al., 2007). The T. brucei RNA 
triphosphatase (TbCET1) catalyzes the removal of the γ-phosphate from triphosphate-
terminated RNA and is a separately encoded enzyme that is structurally and 
mechanistically closer to the fungal and RNA triphosphatase than to metazoan RNA 
triphosphatases(Ho and Shuman, 2001). A (guanine N-7) methyltransferase (TbCMT1) 
has also been characterized (Hall and Ho, 2006a). Sequence alignment between 
TbCMT1 and the corresponding enzymes from humans, fungus, and microsporidia 
showed several conserved residues that are essential for methyltransferase activity (Hall 
and Ho, 2006a). While TbCMT1 can methylate the cap analogues GpppA and GpppG, 
GTP is not a suitable methyl acceptor, suggesting TbCMT1 can discriminate free 
nucleotides to only methylate RNA. On the other hand, its ability to methylate cap 
analogues also suggests the RNA component beyond the first nucleotide is not strictly 
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essential for catalysis (Hall and Ho, 2006a). Knockdown of TbCMT1 by RNAidid not 
show a growth defect in PCF T. brucei (Takagi et al., 2007).   
Interestingly, in addition to the three capping enzymes described, trypanosomatids have 
an additional guanylyltransferase-methyltransferase in the form of a bifunctional 
enzyme (TbCGM1) (Figure 1.6, panel B) (Hall and Ho, 2006a; Takagi et al., 2007).In 
the characterization of this unusual capping enzyme, it has been shown that the N-
terminal domain contains the six signature guanylyltransferase motifs that are conserved 
in the superfamily of capping enzymes and form the active site for GMP binding and 
nucleotide transfer (Ruan et al., 2007; Takagi et al., 2007). The C-terminus of TbCGM1 
contains an S-Adenosyl methionine (SAM) binding motif characteristic of 
methyltransferases as well as several important residues that are involved in the binding 
of the GpppA cap (Hall and Ho, 2006a; Takagi et al., 2007). The concerted mechanisms 
of this enzyme form the 5´ terminal (cap0) structure on SL RNA. TbCGM1 depletion by 
RNAisupported its essentiality in PCF T. brucei (Ruan et al., 2007; Takagi et al., 2007). 
Silencing of TbCGM1 by RNAi also causes defects in cap4 formation seen by the 
accumulation of hypomethylated SL RNA and therein reduced utilization of SL RNA in 
trans-splicing (Ruan et al., 2007; Takagi et al., 2007). Cap0 formation is important as it 
is a pre-requisite for subsequent methylations the SL RNA to form cap4 because the 
cap2 methyltransferase requires the structure m7GpppA for binding and catalysis (Hall 
and Ho, 2006b; Mittra et al., 2008; Takagi et al., 2007). These studies have laid the 
groundwork for understanding the in vivo functions of the capping machinery in T. 
brucei; however, the purpose of the multiplicity of trypanosomatid capping enzymes 
remains unclear.   
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Figure 1.6: The mRNA capping apparatus differs between humans and T. brucei. (A) 
Structure of the 7-methylguanosine cap (cap0) and first four transcribed nucleotides, 
collectively known as cap4. The action of each capping enzyme is depicted by ovals 
of the corresponding color. (B) Humans have a triphosphatase (blue) fused to the 
guanylyltransferase (yellow) and a methyltransferase (green). T. brucei have the 
three enzymes encoded separately plus an additional guanylyltransferase-
methyltransferase bifunctional enzyme.  
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1.7 Post-transcriptional regulation of gene expression in T. brucei 
Although in T. bruceigenes are arranged in tandem arrays and transcribed as 
polycistrons, they are generally unrelated in function or developmental regulation. 
Modulation of mRNA half-life occurs, at least in part, through RNA-binding proteins 
which interact with motifs located in the 3´ untranslated region (UTR) (Clayton, 2002, 
2013). For example, AU-rich elements (AREs) are motifs which stimulate 3´ to 
5´exonuclease activity. Additionally, mRNA turnover is regulated through the activity 
of a decapping enzyme that removes 7-methylguanosine diphosphate (m7GDP) from 
the end of mRNA, as well as by a decapping scavenger activity that interacts with the 
exosome-mediated decay machinery (Irmer and Clayton, 2001; Milone et al., 2002) . 
These degradation pathways are counterbalanced with binding sites for poly(A)-binding 
proteins (PABPs) which prevent mRNA 5´decapping(Hotchkiss et al., 1999). Together, 
these processes allow for dynamic adaptation to variable environments via sub-regions 
in the 3´UTRs that have different effects on mRNA stability throughout the life cycle 
(Milone et al., 2002). The first life cycle specific regulatory sequences identified in T. 
brucei were in the 3´ UTR of VSG mRNA (Berberof et al., 1995). In BSF these 
sequences stimulated expression by stabilizing the mRNA and conversely, in PCF, 
VSGtranslation was shut down through instability and rapid mRNA degradation. Since 
then, similar regulatory motifs have been characterized for several genes (Clayton, 
2002).  The extensive regulatory capacity of RNA-binding proteins is seen in the study 
of RBP6, where over-expression allowed the recapitulation of the T. brucei life cycle 
from the procyclic form trypomastigotes in the tsetse fly midgut to the host infective 
metacyclictrypomastigotes(Kolev et al., 2012).  
In the nucleus, mature mRNAs that have evaded the degradation machinery are 
recognized by the cap binding complex (CBC) via their cap4 structure. 
Trypanosomatids have an unusual CBC consisting of five subunits (compared to the 
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heterodimeric CBC in other eukaryotes) that is essential for cell viability. T. 
brucei CBC binds cap4-containing RNA with significantly greater affinity than m
7
G-
capped RNA, emphasising its uniqueness (Li and Tschudi, 2005). When the CBC 
dissociates from the cap4-RNA, it is subsequently transported into the cytoplasm and 
bound by the cap binding translation initiation factor eIF4E which is a component of the 
heterotrimeric translation initiation complex alongside an RNA helicase, eIF4A, and the 
scaffolding protein eIF4G (Freire et al., 2011; Pereira et al., 2013). The T. brucei family 
of eIF4E cap4 binding proteins has six homologs whose interaction with eIF4G 
mediates the interaction with the newly characterized hypothetical protein eIF4G5-
interacting protein (TbG5-IP) (Freire et al., 2014). This complex facilitates the 
recruitment of the 40S ribosomal subunit to the mRNA and therein translation. The 
existence of multiple initiation factor homologs might suggest the complex serves as an 
mRNA selector to create a co-regulated response to differentiation. These processes of 
transcription, post-transcriptional regulation and translation are consistent between 
bloodstream and procyclic form T. brucei although in order to survive the contrasting 
environments between their host and vector, the parasites must alter their gene 
expression profiles. 
1.8 Differential gene expression throughout the life cycle of T. brucei 
Continuous advances in analytical tools in transcriptomics and proteomics fuel our 
ability to understand interactions and mechanisms unattainable in the past. 
Trypanosome progression from mammalian blood to the flymidgut requires rapid 
changes in protein expression to replace its VSG surface coat with procyclin, and alter 
its metabolism. Further, the parasite must then differentiate into its metacyclic form in 
the salivary glands to restart the cycle. Recent studies using RNA-seq have greatly 
improved our understanding of the T. brucei transcriptional landscape. These studies 
have found approximately a thousand new transcripts, multiple non-coding RNAs, and 
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facilitated the correction of numerous annotations across the T. brucei genome. The 
three research groups who performed these studies observed 5.6-32% of all mRNAs 
were regulated,by at least 2-fold,between BSFand PCF suggests T. brucei controls gene 
expression post-transcriptionally (Kolev et al., 2010; Nilsson et al., 2010; Siegel et al., 
2010). Using RNA-seq it was possible to precisely map previously undefined UTR 
boundaries for genes. The length of a gene’s 5´ UTRs was found to be, on average, 
shorter than its 3´UTR, presumably to accommodate the regulatory motifs found in the 
3´UTR. Interestingly, multiple splice-acceptor sites (SAS) and polyadenylation sites 
(PAS) were discovered per gene, revealing a broad range of alternative SAS and PAS 
that have not been characterized (Kolev et al., 2010; Nilsson et al., 2010; Siegel et al., 
2010). This result implies the extent of gene regulation by different splice variants has 
been underestimated and could lead to interesting research in the future. Further, for 321 
genes, all of the SAS mapped to an initiator ATG site that is downstream of the 
previously annotated coding sequence start-site (Siegel et al., 2010). Additionally, 
RNA-seq enabled the discovery of over a thousand transcripts that were not annotated 
in the T. brucei genome which contain open reading frames (ORFs) and 50 of these 
transcripts contain orthologs in Leishmania and Trypanosoma cruzi. Of these novel 
transcripts, 111 are developmentally regulated between BSF and PCF trypanosomes and 
19 have been detected at the protein level by mass spectrometry (Kolev et al., 2010; 
Nilsson et al., 2010; Siegel et al., 2010). These findings are a transcriptomic gold mine 
of potential regulators of the T. brucei life cycle awaiting discovery.   
1.9 Translational regulation of gene expression in T. brucei 
Investigation of translational control on a global scale has been largely overlooked in T. 
brucei. Nevertheless, there are a few examples of polysome profile analysis used to 
explore differential translation in T. brucei, and recently, the ribosomal profiling 
method has been implemented for the study of T. brucei gene expression regulation 
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(Brecht and Parsons, 1998; Capewell et al., 2013; Vasquez et al., 2014). The 
quantification of translated RNA transcripts is achieved by isolating the transcripts from 
the polyribosome fractions of a sucrose gradient (Dickson and Brown, 1998). Although 
ribosomes could be associated with the 5´ UTR or stalled, polysome associated 
transcripts are considered more likely to be actively translated (Gross et al., 2003; 
Ingolia et al., 2009; Sagliocco et al., 1993). The ribosome profiling method involves 
isolating ribosome-protected RNA fragments combined with RNA-seq to map the 
ribosome ‘footprints’. Protein expression is then estimated from the density of the 
ribosome footprints (Ingolia et al., 2009). In T. brucei, ribosomal profiling showed a 
large variation in translational efficiency both within an individual life cycle stage, and 
comparatively between bloodstream and procyclic form cells. This suggests the 
translation of mRNA to protein is an important regulatory step in T. brucei, consistent 
with observations in other eukaryotes (Ingolia et al., 2009, 2011; Vasquez et al., 2014).  
1.10 Comparative transcriptomics and proteomics in T. brucei 
There are many genes for which the reported life cycle regulation of mRNA does not 
correlate with the observed protein levels: RAB18, transketolase, and CAP5.5 to name a 
few (Hertz-Fowler et al., 2001; Jeffries et al., 2002; Stoffel et al., 2011). Unlike the 
small number of life stage-regulated transcript changes (5.6-32%) discussed above, 
changes in the protein levels vary drastically between life stages. However, the 
relationship between transcript and protein abundance is not yet well understood 
(Urbaniak et al., 2012, 2013). The correlation between stable isotope labelling by amino 
acids in cell culture (SILAC) comparative proteomic data and microarray 
transcriptomics studies in T. brucei was examined and the mRNA abundance from two 
different studies (Jensen et al., R=0.86, Queiroz et al., R=0.83) correlated well with 
protein (Jensen et al., 2009; Queiroz et al., 2009; Urbaniak et al., 2012). Strong 
correlation between mRNA and protein levels combined with RNA-seq and 
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translational profiling have made important contributions to the understanding of how 
trypanosomes adapt throughout their life cycle.   
1.11 Aims of the thesis 
 
Aim 1:To explore the essentiality and function of the bifunctional capping enzyme and 
monomeric methyltransferase. This will be accomplished by:  
a) Generation of conditional null mutants of the monomeric methyltransferase 
(TbCMT1) and the bifunctional methyltransferase/guanylyltransferase 
(TbCGM1). 
b) Investigating the effects of loss of TbCMT1 function on in vivo cell viability, the 
T. brucei transcriptome and translation. 
 
Aim 2:  To investigate the possibility that some of the mRNA 5´ cap nucleosides in T. 
brucei are structurally different from conventional 7-methylguanosine. To achieve this,  
a method was developed to isolate the cap from endogenous mRNA and analyse the 
resulting structure by mass spectrometry. The possibility of novel mRNA cap 
structure(s) was suggested by the existence of an additional 
guanylyltransferase/methyltransferase (TbCGM1) found in kinetoplastids but not other 
eukaryotes. Specifically, a method will be developed to isolate endogenous mRNA 
capping nucleosides from trypanosome mRNA preparations and identify the resulting 
structure(s)using LC-MS/MS as the primary analytical tool. The methodology will be 
developed using commercially available methyl cap standards and, subsequently, 
human (HEK293 cell) mRNA.  
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Aim 3: To investigatemRNA recruitment to ribosomes as a component of gene 
expression regulation in trypanosomes using RNA-seq of total polyA+, subpolysomal, 
and polyribosomal mRNA purified from bloodstream and procyclic form T. 
brucei,followed by bioinformatic analysis comparing transcript and proteomic profiles.  
Categorized genes that are over/under-represented on polysomes relative to total mRNA 
will be used to ask the following questions: 
a) What biological processes and pathways are genes that are over/under 
represented on polysomes associated with? 
b) Can we perturb these pathways and observe transcripts moving into/out of 
polysomes? 
c) Do polysomal mRNA ratios between BSF and PCF trypanosomes have a better 
correlation with observed protein levels than total mRNA? 
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MATERIALS AND METHODS 
2.1 Trypanosoma brucei cell culture growth conditions 
 
Bloodstream form T. brucei cell line and media 
 
T. brucei bloodstream form cells (strain 427, VSG variant MIT-aT 1.2) were cultured at 
37°C with 5% CO2 in cell culture flasks with filter lids (Greiner). Cells were grown to a 
maximum density of 3x10
6
cells/ml in HMI-9t medium. HMI-9t contains variations on 
the HMI-9 medium described in(Hirumi and Hirumi, 1994):  thioglycerol(Sigma) was 
used instead of β-mercaptoethanol, and GlutaMAX (Gibco) was used instead of L-
glutamine in both cases because of increased stability. All null and conditional null 
mutants were generated from the single marker (SM) cell line, which expresses a T7 
polymerase and a tetracycline repressor protein (TetR) under neomycin (G418) 
selection (Wirtz et al., 1999). Table 2.1 lists the concentration of antibiotics used to 
maintain selection. 
T. brucei procyclic form transgenic cell line 29.13.6 was cultured at 28°C in Becton 
Dickinson culture flasks. Cells were grown to a maximum density of 4x10
7
 cells/ml in 
SDM-79 medium (Brun and Schonenberger, 1979) supplemented with 15% fetal bovine 
serum (FBS) (PAA), GlutaMAX (Gibco), and 15µg/ml hemin (Sigma). Known as the 
double marker (DM) cell line, these cells were used for polysomal profiling and RNA-
seq. Similar to SM cell line, the DM cell line was modified to contain a T7 polymerase 
and a tetracycline repressor protein (TetR) under G418 and hygromycin (HYG) 
selection(Wirtz et al., 1999). Table 2.1 lists the concentration of antibiotics used to 
maintain selection. 
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Table 2.1: Antibiotics used in T. brucei cell culture and genetic manipulation 
 
Tetracycline (Calbiochem) was prepared fresh every seven days at 10 mg/ml in 70% 
ethanol and added to the cell culture every two days to maintain expression from the 
tetracycline inducible promoters. For growth curves of conditional null mutants, 
tetracycline was removed from the culture by washing the cells three times in medium 
without the drug and then inoculating cultures in the presence or absence of tet. For 
RNAi experiments, cells were induced with 1 µg/ml tetracycline every 24 h for 
effective knockdown.  
Both bloodstream form and procyclic form T. brucei were counted using the CASY Cell 
Counter + Analyser system. To stay within the linear range of the cell counter, procyclic 
form cells were diluted 1:10 in PBS before being diluted in the CASY-ton solution for 
measurement.  The system displays the average of three measurements of the culture’s 
cell density as well as average cell volume.  
Generating stabilates 
Bloodstream form T. brucei were grown to 2x10
6
 cells/ml, centrifuged (800 g, 10 min, 
4°C in 4K15 Sigma centrifuge). The pellet was resuspended in 1 ml ‘freezing media’ 
(HMI-9t medium without antibiotics and with 10% glycerol) per every 3 ml of culture. 
The cells were then aliquoted 1 ml per Cryovial (Nalgene). Procyclic form T. brucei 
were grown to 2x10
7
 cells/ml, centrifuged (600 g, 10 min 4°C). The pellet was then 
resuspended in 1 ml ‘freezing media’ (SDM-79 with 10% glycerol) per every 5 ml of 
initial culture. The cells were then aliquoted1 ml per Cryovial (Nalgene). For both cell 
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lines, the Cryovials were either frozen overnight in a freezing chamber containing 
isopropanol (Nalgene) or in a Revco Benchtop Ultra-low temperature -80ºC freezer and 
then stored in a K-series cryostorage unit (Jencons). 
2.2 Protocols for generation of null and conditional null mutants 
 
Gene replacement constructs 
 
The open reading frames and flanking regions of genes were obtained using T. brucei 
database (www.tritrpydb.org) using the gene accession numbers: monomeric 
methyltransferase TbCMT1 – Tb927.10.4500, guanylyltransferase-methyltransferase 
bifunctional enzyme TbCGM1 – Tb927.7.2080, and monomeric guanylyltransferase 
TbCE1 – Tb927.11.14580.  Plasmid construct sequences were assembled in silicousing 
CLC Main Workbench v6 software (CLC Bio). The primers used to amplify UTRs for 
the gene replacement construct and the ORF for overexpression vectors are listed in 
Table 2.2. Primers were designed to contain ~20 bp of complementary sequence, have a 
guanine or cytosine at their 5´ and 3´ ends, a melting temperature (Tm) around 60°C, 
and less than 2°C difference in Tm between a pair of primers. The primers were designed 
using the NCBI-PrimerBLAST tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) 
which uses the program Primer3 to design the PCR primers and then uses the BLAST 
algorithm to screen the primers against the T. brucei genome in order to avoid primer 
pairs that can create non-specific amplifications(Ye et al., 2012).All of the primers were 
synthesized by Eurofins Genomics.  
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Table 2.2: List of primers for gene replacement constructs 
 
 
 
 
 
Table 2.3: List of plasmids 
 
 
 
 
 
      Plasmid                           Use                                                     Source 
      pGEM5zF               gene replacement constructs                                  PromegapLEW 
100-3xMYC     tetracycline inducible expression of ectopic           Wirtz, et al., 1999 
                                               copy gene with 3 C-terminal MYC tags 
pLEW100v5-3xHA               tetracycline inducible expression of ectopic            Wirtz, et al., 1999 
                                               copy gene (~10 fold greater than pLEW 100)        modified by L. Güther 
                                               with 3 C-terminal HA tags 
Gene  Name   SequenceFunction 
5’ UTR – Forward 
 
5’ UTR – Reverse 
 
3´ UTR – Forward 
 
3´ UTR – Reverse 
 
ORF – Forwardfor pLEW 100v5 
 
ORF – Reverse for pLEW 100v5 
 
TbCGM1 
Tb927.7.2080  
 
 
 
 
 
 
 
5’ UTR – F 
 
5’ UTR – R 
 
3´ UTR – F 
 
3´ UTR – R 
 
ORF – F  
 
ORF – R  
 
 
TbCMT1 
Tb927.10.4500 
 
 
 
 
 
 
5’ UTR – F 
 
5’ UTR – R 
 
3´ UTR – F 
 
3´ UTR – R 
 
ORF – F  
 
ORF – R  
 
 
ATA AGT ATG CGG CCG CGC ACT CGC AGC  
GCT ATC CAG TTA TCC 
GTT TAA ACT TAC GGA CCG TCA AGC TTT  
AAG GTT ACG CTT TCA CCC CTT 
GAC GGT CCG TAA GTT TAA ACG GAT CCG  
GAG TAC TTA TCT CCC CGT TTT C 
ATA AGT AAG CGG CCG CGC TGG CAT ACA  
GGT GAC TGG CTT C 
ATA AGT ATC ATA TGG AGA GCC TAC GGA  
CTG CAG C 
ATA AGT AAC TCG AGC TGC TGG CTT TCC  
GGA AGC ACA AC 
5’ UTR – Forward 
 
5’ UTR – Reverse 
 
3´ UTR – Forward 
 
3´ UTR – Reverse 
 
ORF – Forwardfor pLEW 100 
 
ORF – Reversefor pLEW 100 
 
ATA AGT ATG CGG CCG CCA AAT CTA ACA  
GAA ACA CCC CAA G 
GTT TAA ACT TAC GGA CCG TCA AGC TTT  
CCC CTC CGA GTG ACT ATT CC 
GAC GGT CCG TAA GTT TAA ACG GAT CCG  
GCG TGT CGG CCA GCA CTG AAA AC 
ATA AGT AAG CGG CCG CCG ACC GCG ACC  
GCC ACC TC 
ATA AGT ATC ATA TGG AAT CGA CGA GTT  
CAC TTT CGG 
ATA AGT AAC TCG AGC TAA TCT TGA CGA  
ACA AGA AGG 
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Polymerase chain reactions (PCRs) for amplification of UTRs, ORFs, and Southern 
probe templates were performed using KOD Hot Start DNA polymerase (Novagen) in a 
PTC-225 Peltier Thermal Cycler (MJ Research) with the following reaction conditions 
and programs. 
 
Table 2.4: PCR reaction components and amplification program 
 
When joining the UTRs in the gene replacement construct, an alternate PCR program 
was used. The two UTRs were fist annealed via the pre-determined complementary 
sequence (in the absence of primers) followed by amplification of the combined 
fragment by the addition of KOD Hot Start DNA polymerase and the 5´ UTR – F and  
3´ UTR – R primers (Figure 3.1, Table 2.5). 
 
 
 
 
 
 
 1   95  2 min
 1   95               15 sec 
 1   55(Tm-5ºC)        30 sec 
 1   72            20sec/kbp 
 1   72                 2 min 
     4                     ∞ 
   Reaction Mix (per 50 µl) 
   5 µl of 10x KOD Hot PCR Buffer 
   5 µl dNTPs (0.2mM each) 
   2 µl MgSO4(1mM) 
   template (50 ng for plasmid, 100 ng for gDNA) 
   1.5 µl 5’ primer (15 pmol) 
   1.5µl 3´ primer (15 pmol) 
   1 µl KOD Hot Start DNA polymerase (1U) 
   up to 50 µl with nuclease-free H2O 
                  Amplification Program 
    #of Cycles      T (ºC)                    Time 
x30 
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Table 2.5: Annealing PCR reaction for joining UTRs 
 
PCR reaction products were separated by agarose gel electrophoresis. DNA was 
analysed on 1 % w/v agarose (Electran agarose, VWR) gels in 1x TAE buffer (40 
mMTris-acetate, 1 mM EDTA) containing 0.4 µg/ml ethidium bromide. For Southern 
blotting, 0.8% gels were used under the same conditions. The DNA samples were 
diluted with 6x Blue/Orange Loading Dye (Promega) and the 1 kb DNA ladder 
(Promega) was used to estimate the size of DNA fragments. The agarose gels were run 
at 80 V in 1x TAE buffer using BioRad Mini-Sub Cell GT tanks connected to Power 
Pac 300 power packs. Gels were imaged on a UV Transilluminator and captured on 
aUGenius gel documentation system (Syngene). Following confirmation the PCR 
products were the correct size, the remaining PCR reaction mixture was purified using 
the QIAquickPCR Purification Kit (Qiagen) per manufacturer’s protocol. DNA 
concentration was estimated by A260 and purity by A260/A280 and A260/A230 on the 
nanodrop 2000c spectrophotometer (Thermo).   
All restriction enzymes were purchased from NEB. Restriction digests were performed 
in the recommended buffer O/N in a 37°C stationary incubator for cloning or plasmid 
linearization prior to T. brucei electroporation. For analytical digests to screen several 
 1   95               30 sec
 1   95               30 sec 
 1   50                       45 sec 
 1   68               1 min  
  
1   95               30 sec
 1   95               30 sec 
 1   60                       45 sec 
 1   68               1 min 
               1              68                      10 min  
x25 
   Reaction Mix (per 50 µl) 
   5 µl of 10x KOD Hot PCR Buffer 
   5 µl dNTPs (0.2mM each) 
   2 µl MgSO4(1mM) 
   50 ng each UTR fragment  
   1 µl KOD Hot Start DNA polymerase (1U)    
   up to 50 µl with nuclease-free H2O 
 
    after linking PCR add: 
   1.5 µl 5’ UTR – F primer (15 pmol) 
   1.5µl 3´ UTR – R primer (15 pmol) 
                  Amplification Program 
    #of Cycles      T (ºC)                    Time 
x5 
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selected plasmid clones, restriction digest was carried out for 2 h in a 37°C water bath. 
Restriction digest products were separated by agarose gel electrophoresis as described 
above and the correct size DNA bands were excised from the gel and purified using the 
QIAquick Gel Extraction Kit (Qiagen) per manufacturer’s protocol. After endonuclease 
digestion, plasmids were dephosphorylated to reduce probability of re-ligation. The 
plasmids were incubated at 37°C for 30 min with Antarctic Phosphatase (NEB) 
followed by heat inactivation at 65°C for 20 min.The concentrations of digested plasmid 
vector and insert were estimated by measuring the A260on the spectrophotometer. Three 
different ratios of insert to vector were tried for each ligation, 1:1, 1:3 and 1:7 
(vector:insert). A ligation reaction without insert was set up as a control for vector re-
ligation. The ligation reactions were set up in 10 µl volumes using the T4 DNA ligase 
and associated 10x ligation buffer (Promega).The reactions were incubated at RT for 2 h 
and 1µl of each was transformed into Silverselect competent cells (Invitrogen). 
Competent cells were transformed by incubating the plasmid with 50 µl competent cells 
on ice for 30 min, heat shocking the cells at 42ºC for 45 sec, allowing the cells to 
recover from the heat shock on ice for 2 min, adding 250 µl SOC media to allow the 
cells an outgrowth period (without selection antibiotic) of 1 h in a shaking  
37ºC incubator, plating the transformed cells onto LB+ampicillin (amp) agar plates and 
incubating the plates at 37ºC O/N. Once colonies were selected and grown O/N in 5 ml 
LB+amp medium, the plasmid DNA was purified using a Miniprep Kit (Qiagen)and its 
sequence verified by endonuclease digestion and sequencing (University of Dundee, 
College of Life Sciences, DNA sequencing service). For stabilates of E. coli, a well 
grown (16h) culture was supplemented with 10% glycerol (AnalaR, VWR) and stored at 
-80°C. StabilatedE. coli cells were revived by inoculation into LB+amp media and 
grown overnight at 37°C. All media were obtained from the Media Kitchen service in 
the College of Life Sciences, University of Dundee. 
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Completed constructs (10 µg) were linearized by digestion with the NotI (NEB) 
restriction enzyme as described above and purified by ethanol precipitation. For each 
volume of digested plasmid DNA, 3M sodium acetate pH 5 was added at 1/10 of the 
volume, followed by 2 times the volume cold 100% ethanol. The solutions were mixed 
and incubated at -80°C for at least 2 h. After incubation, the precipitated DNA was 
pelleted by centrifugation (30 min, 16,000 x g, 4°C). The supernatant was carefully 
decanted to not disturb the pellet which was then washed with 1 ml cold 70% ethanol. 
After decanting the wash, the ethanol was left to air-dry for 10 min and then the pellet 
was resuspended in sterile water at a concentration of 200 ng/µl. 
 
Bloodstream form T. brucei electroporation 
 
Gene replacement constructs were prepared for electroporation by digestion with the 
NotI restriction enzyme to release the resistance cassette and UTRs from the pGEM 
vector backbone. Bloodstream form cells grown to mid log phase density (2x10
6
 
cells/ml), were counted and 1x10
7
 cells/cuvette were centrifuged (800 x g, 10 min, RT) 
and resuspended in 100 µl/cuvette of either in Amaxa Human T-Cell Nucleofector 
solution containing supplement (Lonza) or Cytomix solution (2mM EGTA p.H. 7.6, 
120mMKCl, 0.15mMCaCl2, 10mM K2HPO4/KH2PO4 pH 7.6, 25mM HEPES pH 7.6, 
5mMMgCl2·6H2O, 0.5%Glucose (Dextrose), 100 µg/mlBSA, 1mMHypoxanthine. 
Plasmid DNA (1µg) was combined with the 100 µl of cell suspension into each of7 
cuvettes (Amaxa certified, included in the Nucleofector kit, or BioRad) and 1 cuvette 
with water in place of DNA as a negative control and measure of the amount of time 
necessary for antibiotic selection. The cells were electroporated using an 
AmaxaNucleofector II, program X-001 (Burkard et al., 2007). After the electroporation, 
the cells from each cuvette were recovered in a flask with 12 ml of HMI-9t without the 
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selection antibioticfor 14 h at 37°C before 12 ml of medium containing twice the 
concentration of selection antibiotic (puromycin or hygromycin) was added to each 
flask.  
When the pLew100 or pLEW100v5 constructs were prepared for electroporation, 
plasmids were linearized with NotI restriction enzyme and purified by ethanol 
precipitation. For electroporation, 2 cuvettes were transfected with the construct and 1 
negative control cuvette with water. HMI-9t media containing phleomycin was added to 
the flask after the usual recovery time at 37°C. Antibiotic selection was deemed 
complete when cells that were electroporated without DNA were completely dead. 
Resistant cells were plated into 96-well plates (Grenier) at a concentration of 1 cell/ml 
to ensure the resistant cells were a clonal population. Cells from five of the wells were 
chosen to establish in culture and their genotype was analysed by Southern blot.  
2.3Protocols for characterization of null and conditional null mutants 
 
Isolation of bloodstream form T. brucei genomic DNA 
Log phase density bloodstream form T. brucei(1x10
8
cells) werecentrifuged (800 xg, 10 
min, 4°C). The cells were then lysed by resuspending in 1 ml DNAzol (Helena 
Biosciences) and incubated for 30 min at RT. To precipitate the gDNA, 0.5 ml of 
absolute ethanol was added, inverted gently until the mixture was homogeneous, and 
then centrifuged (5000xg, 10 min, RT) in a microcentrifuge, Eppendorf. The 
supernatant was discarded and the gDNApellet was washed with 70% ethanol (5000xg, 
2 min, RT). The wash was decanted and the pelleted gDNA was left to air-dry for 5 min 
before being re-dissolved in 50-100 µl of nuclease-free water at 50°C. The 
concentration of the purified genomic DNA was estimated by A260 and purity by 
A260/A280 and A260/A230 on the nanodrop 2000c spectrophotometer (Thermo). 
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Southern blot analysis 
 
Approximately 5 µg of genomic DNA were digested at 37°C for 16 h with chosen 
restriction endonucleases in their appropriate 10x buffer and the fragmented gDNA was 
run on a 0.8% agarose gel (in a longer gel tray to increase resolution of genomic 
fragments) with ethidium bromide and imaged as described above for PCR products. 
The gel was then prepared for transfer by washing it for 10 min in 0.2 M HCl, then 15 
min in 0.5M NaOH, 1.5M NaCl and finally for 20 min in 1M Tris-HCl pH 7.5, 1.5M 
NaCl. All of the washes were carried out at room temperature while shaking. The 
gDNA was then transferred on to a positively charged nylon membrane (Roche) by 
capillary action (Figure 2.1). The transfer was performed for a minimum of 2 hr (usually 
overnight) in 10x sodium chloride, sodium citrate (SSC) buffer (3M NaCl, 300 mM 
Na3C6H5O7, pH 7) provided by the Media Service Facility, College of Life Sciences, 
University of Dundee. After the transfer, the DNA was cross-linked to the membrane 
using 1200 UV counts on a CL-1000 (UVP) UV cross-linker.   
 
 
Figure 2.1: Southern blot transfer set up of fragmented gDNA from the agarose gel 
to the nylon membrane.   
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The DNA probe for the Southern blot was synthesized using the PCR DIG Probe 
Synthesis Kit (Roche). A control PCR without the DIG labelled dNTPs was also 
performed to ensure the PCR synthesis was successful. Both PCR reactions were then 
analysed by gel electrophoresis to verify the size increase of the labelled probe and 
approximate the amount synthesized. After crosslinking, the membrane was placed in a 
roller bottle (Techne) and incubated with 10 ml of the pre-hybridization EasyHyb 
solution (Roche) for 30 min at 42°C followed by overnight incubation at 42°C with 10 
µl of (denatured DIG-labelled) probe in 20 ml fresh EasyHyb solution. Following 
hybridization, the membrane was washed 2x (5min, 1x SSC, 0.1% SDS, 48°C) and 2x 
(15min, 0.5x SSC, 0.1% SDS, 65°C). The membrane was then allowed to cool to RT 
before 1x (wash buffer, 5 min) followed by incubation in blocking buffer for 30 min, 
RT (Roche). Anti-DIG AP-conjugate antibody (Roche) was diluted 1:10,000 in 
blocking buffer and incubated with the membrane for 30 min, RT. Non-specific 
antibody was washed 2x (wash buffer, 15 min, RT) and 1x (detection buffer, 5 min, 
RT). The membrane is the incubated in CSPD detection reagent (Roche) for 5 min, RT 
and finally for 10 min, 37°C. Membrane was exposed between 30 sec and 3 min using 
Hyperfilm (Kodak) in a Compact X4 developer.   
qRT-PCR analysis of transcript depletion in conditional null mutants grown in non-
permissive condtions and RNAi knockdown 
 
Total RNAwas extracted from bloodstream form T. brucei using the RNeasy Mini 
Extraction Kit (Qiagen). Protocol was carried out according to manufacturer’s 
instructions with a few deviations for T. brucei. Cells were centrifuged for 10 min, 
800xgat RT in a 4K15 Sigma centrifuge, media was aspirated and the cell pellet was 
resuspended inbuffer RLT and β-mercaptoethanol was added at a 1:100 dilution.One 
volume of 70% ethanol was added to the lysate and the homogenous mixture was 
transferred to the provided column. RNA was bound to the column by centrifugation 
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for15 sec, 10, 000xg. The column was then washed with Buffer RWI and twice with 
Buffer RPE. Following the washes, the column was transferred to a sterile (RNAse free) 
Eppendorf tub, and the RNA was eluted in 50 µlRNase-free H2O. The RNA 
concentration was then estimated by the A260value of the nanodrop 2000c 
spectrophotometer (Thermo) with adjusted the path length setting (40) for RNA.cDNA 
was synthesized from the purified total RNA using the iScript cDNA Synthesis Kit 
(BioRad). A negative control reaction (without reverse transcriptase enzyme was 
performed in parallel to ensure the absence of gDNA in the samples. The components of 
the reaction were as follows. 
Table 2.6: cDNA synthesis reaction components and amplification program 
 
Following RNA purification, and cDNA synthesis gene specific (Table. 2.8) mRNA 
levelsin were quantified by performing qRT-PCR using Sybrgreen master mix (Bio-
Rad). The reaction was performed using a Bio-Rad iCycler Thermal Cycler.  
 
 
 
 
 
 
 
 1   25  5 min
 1   42               30 min 
 1   85                       5 min 
     4                     ∞ 
   Reaction Mix (per 20 µl) 
   4 µl of 5x iScript reaction mix 
      template (500 ng total RNA) 
   1 µl  iScript reverse transcriptase 
   up to 20 µl with nuclease-free H2O 
      
                  Amplification Program 
    #of Cycles      T (ºC)                    Time 
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Table 2.7: qRT-PCR reaction components and amplification program 
 
Table 2.8: List of primers for qRT-PCR of capping enzymes 
 
T. brucei crude cell lysate for Western blot analysis of ectopic copy 
 
Bloodstream form T. brucei cells grown to log phase density and 1x10
6
cells were 
harvested by centrifugation (800 x g, 10 min, 4°C) and washed twice in 1x TDB at 4°C. 
Next, cells were transferred to an Eppendorf tube and pelleted(10sec, 10,000xg, 4°C). 
The cells were then resuspended in 10 µl TDB buffer and lysed by addition of 4x 
sample buffer (Invitrogen). The cell lysate was heated 100°C for 10 min before loading 
onto a pre-cast Novex 4-12% Bis-Tris gels with MOPS running buffer (Invitrogen) at 
200 V for 1.5 hours. 
 
 
Gene  Name   SequenceFunction 
qRT-amplicon-F 
qRT-amplicon-R 
 
TbCGM1 
 
 
 
qRT-PCR – F 
qRT-PCR – R 
 
 
TbCMT1 
 
 
qRT-PCR – F 
qRT-PCR – R 
 
GGG AGC AAT TGC CAA AGC 
CAC GCT TCG CCA GAA C 
qRT-amplicon-F 
qRT-amplicon-R 
 
TCA ACG GGA AAG AAT CGT AGC A 
CAC CAT ACC ATC GTT GTC GAG C 
 1   50  2 min
 1   95               10 min 
 1   95                       15 sec 
               1              60                       30 sec 
               1              72                       30 sec 
     4                     ∞ 
x40 
   Reaction Mix (per 20 µl) 
   10 µl of 2x SYBR Green reaction mix 
    3 µl  of cDNA template (1:50 dilution) 
   0.6 µl  forward primer (10 µM) 
   0.6 µl  reverse primer  (10µM) 
   up to 20 µl with nuclease-free H2O 
      
Amplification Program 
    #of Cycles      T (ºC)                    Time 
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Table 2.9: 5x Trypanosome Dilution Buffer (TDB) 
 
Following protein separation by SDS-PAGE, the proteins were transferred onto a 
nitrocellulose membrane using theiBlot system (Invitrogen) on ‘Program 3´ for 7 
minutes. The membrane was then incubated for 5 min in Ponceau S (Sigma) to verify 
proteins transfer and then blocked in blocking buffer (50mM Tris Base, 0.15M NaCl, 
0.25% (w/v) BSA, 0.05% Tween 20, 0.05% NaN3, 2% fish skin gelatin (FSG), pH 7.4) 
for 1 h. The primary antibody (α-HA)(Millipore) was diluted 1:1000 in blocking buffer 
and incubated with the membrane in the SNAPid chamber (Merck) for 1 h at RT, 
rotating. After incubation, the membrane was washed 3x 35 ml wash buffer (1x PBS, 
0.05% Tween-20) in the SNAPid vacuum manifold. IRDye(α-mouse)secondary 
antibody were diluted 1:15,000 in blocking buffer and incubated with the membrane for 
1 h at RT, rotating. Membrane was imaged on the Licor system (700 channel – red 
(ladder), 800 channel – green (sample)). 
Growth curve analysis of null and conditional null mutant T. brucei 
 
For the growth curves the T. brucei BSF conditional null cells were washed 3x in TDB 
buffer to remove residual tetracycline from the media, and resuspended at either 5×10
4
 
cells/mL. Null cell lines were diluted without washing. Cells were counted every 2 days 
using the CasyCounter followed by dilution of each culture to 5×10
4 
cells/ml (1 µg/ml 
tetracyclin was added every day to conditional null cells grown in permissive 
conditions). Growth curves were conducted in biological triplicates.  
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Mouse infectivity study 
 
TbCMT1 null and conditional null cells were subcultured and conditional null cells 
were grown with 1µg/ml tetracyclin. Groups of five (BALb/C) mice (dosed with and 
without doxycycline) were infected with 200 µl containing 2x10
5
 parasites by 
intraperitoneal injection (Fred Simeons and LasteStojanovski, University of Dundee). 
Doxycycline was added to the drinking water (0.2 mg/ml) in a 5% sucrose solution) of 
the group of animals that was to be dosed with for 1 week before infection and until the 
experiment was terminated. Infections were assessed by tail bleeding and cell counting 
in triplicate.  
2.4Protocols for RNAi knockdown 
 
RNAi knockdown construct generation, electroporation and phenotype analysis 
 
A 535 bp fragment of TbCGM1 was amplified by PCR and cloned into the pRPa
iSL
 
tagged locus, incudible stem-loop RNAi vector (a kind gift of the Horn Lab) with two 
sequential steps (Figure 2.2). The anti-sense strand was cloned using restriction 
endonucleases Acc651 and BamHI, and the sense strand was subsequently cloned using 
restriction endonucleases Bsp1201 and XbaI. Knockdown fragment was selected using 
(http://trypanofan.bioc.cam.ac.uk) on-line resource and the sequence for TbCGM1 
(Tb427.7.2080). This vector contains a tetracycline-inducible rRNA promoter which 
generates a stem loop RNAi transcripts. The resulting construct was linearized with 
AscI and 2.5x10
7
T. brucei 2T1 cells (another kind gift of the Horn lab) were 
electroportated with 10µg linearized construct which integrates into a specific 
rRNAspacer locus.Hygromycin (2.5 µg/ml, Sigma) was added 6 hours post-transfection 
and assayed for puromycin sensitivity. RNAi induced cells were grown in the presence 
of tetracycline (1µg/ml each day) and grown in parallel with uninduced cells. Every 24 
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hr cultures were counted and diluted to 1x10
5
. Gene knockdown was assessed by qRT-
PCR using gene specific primers (Table 2.10).  
Table 2.10:TbCGM1 RNAi knockdown construct primers 
Name Sequence 
TbCGM1-RNAi-F GAT CGG GCC CGG TAC CGT CGA CTG GAG CCT AAC AGC 
TbCGM1-RNAi-R GAT CTC TAG AGG ATC CGT ACG CCC CAG TAA AGG TGA 
 
2.5 Analytical methods for the analysis of nucleotide structure by mass spectrometry 
 
TFA hydrolysis 
 
Aliquots of 50 nmol of standards (GDP, GTP, m7GpppG) were hydrolysed by the 
addition of 250 µl freshly prepared 0.1 M TFA (20 min, 100°C). The reaction was 
stopped by flash freezing in liquid N2 and reaction products were freeze-dried in a 
freeze dryer overnight. Samples were then redissolved in 10 µl water for TLC analysis 
of Buffer A for analysis by LC-MS/MS (Table 2.11).   
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Figure 2.2: Sequence of TbCGM1. The bifunctional enzyme contains an N-terminal 
guanylyltransferase (blue) and a C-terminal methyltransferase (yellow). Gene 
fragment used for RNAi knockdown highlighted in red.    
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Table 2.11: HPLC buffer composition 
 
TLC analysis 
 
Thin layer chromatography was performed on 10 cm high PEI Cellulose-F (Merck) with 
0.35M LiCl, 3.5M Urea as the mobile phase.  Plates were by UV at 254 nm. 
Electrospray mass spectrometry of cap structures 
 
Initial experiments were performed on an Ultima Triple Quadropole mass spectrometer 
(Waters) in negative ion mode by direct infusion. Typical conditions were: Capillary 
voltage = -3kV, Cone voltage = -40V, Source temp = 110, Desolvation temp = 250, 
Desolvation gas = 500. The flow rate was 10 µl per minute, delivered using a 100 µl 
syringe (Hamilton) and a Harvard syringe pump. Spectra were collected, analysed and 
processed using Masslynx software (Micromass). For daughter ion scanning, conditions 
were as above with collision energy of 20V.  
Later experiments were done on the QTRAP 4000 (Applied Biosystems) using 
Precursor ion (m/z 159) negative scanning mode with a nanospray ion source. Samples 
were also performed by direct infusion into an UltiMate 3000 HPLC (Dionex). Samples 
were separated on HPLC using a 40 min gradient from 0-90% buffer B. Typical MS/MS 
conditions were: mass range = 360-600, over 10 sec. Declustering Potential (DP) = -70, 
collision cell entrance potential (EP) = -8, collision cell exit potential = -12, collision 
energy = -30V. Curtain gas = 30, Collision gas = 11, IonSpray voltage = -2000, Ion 
Source gas I = 25, interface heater temp = 175 °C.  
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HEK-293 cell harvest and total RNA purification 
 
HEK-293 WT cells were a kind gift of the MRC tissue culture facility, University of 
Dundee. Media was aspirated from a flask of confluent HEK-293 WT cells, and the 
cells were washed once in 5 ml of PBS, centrifuged (1700 RPM, 5 min, 4ºC) and the 
pellet was resuspended in 1 ml TRIzol Reagent (Ambion). Homogenized cells could be 
stored at -80ºC for up to 1 month. Once thawed from frozen, 200 µl of chloroform was 
added to the lysate and votexed for 15 sec. The mixture was then centrifuged to separate 
the phases (13,000 x g, 15 min, 4ºC) and 475 µl of the aqueous phase was transferred 
into a new RNAse-free tube. It is important not to contaminate the RNA-containing 
aqueous phase with the interphase portion of the homogenized sample when pipetting. 
The RNA is precipitated by the addition of 500 µl of 100% isopropanol to the aqueous 
phase isolated in the previous step, incubated at RT for 10 min and centrifuged (12,000 
x g, 10min, 4ºC). To wash the RNA pellet, the supernatant was removed, replaced with 
1 ml of 75% ethanol, centrifuged (7500 x g, 5 min, 4ºC), and the wash discarded. The 
RNA pellet was then air dried for 10 min, resuspended in 30 µl diethylpyrocarbonate 
(DEPC) water, and stored at -80ºC. 
2.6 Polysome profile analysis 
 
Polysome fractionation and RNA extraction 
 
Procyclic form T. brucei were grown to log phase growth at 28°C without CO2 in SDM-
79 medium, and bloodstream form T. brucei were grown to log phase growth at 37°C 
with 5% CO2 in HMI9-T medium. Polysomes were prepared by resolving a native 
cytosolic extract through a sucrose gradient. Cultures of T. brucei cells were incubated 
with 50 µg/ml cycloheximide for 10 min prior to the start of polysome purification 
procedure. Cells were pelleted by centrifugation at 4°C and PCF cells were washed with 
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PBS containing cycloheximide (137 mMNaCl, 2.7 mMKCl, 10 mM Na2HPO4 • 2 H2O, 
2 mM KH2PO4, 1 mg/ml cycloheximide, pH 7.4), while BSF cells were washed with 
TDB containing 1mg/ml cycloheximide. Cells were resuspended in polysome lysis 
buffer (120 mMKCl, 2 mM MgCl2, 20 mMTris pH 7.5, 1 mM DTT, 1% n-
octylglycoside, 50 µl RNAsin, 2 µg/ml leupeptin, 1 µg/ml aprotinin, 1 µM TLCK, 1mM 
PMSF, 1mg/ml cycloheximide). The detergent n-octylglycoside(NOG) was chosen 
because it does not absorb at 254 nm. The lysates were loaded on top of 10 ml sucrose 
gradients (5 increments, 2ml each: 10%–50%) and centrifuged for 2 h at 38,000 rpm at 
4°C in a Beckman ultracentrifuge using a SW41Ti rotor. Gradients were fractionated 
(0.5 ml fractions) and analysed for nucleic acid content by a Nanodrop 
spectrophotometer at 254 nm. RNA was purified using an RNeasy kit (Quiagen) from 
each fraction and from pooled subpolysome and polyribosomal fractions. Gradient 
analysis was also performed using a gradient collector (Teledyne) with continuous 
monitoring at 254 nm. Individual fractions were collected with a Foxy Jr. (Teledyne) 
fraction collector want RNA was purified as above. The RNA was quantitated and 
checked for purity by Nanodrop spectrophotometer and used for qRT-PCR analysis or 
RNA-seq cDNA library preparation.  
Polysome fractionation and RNA extraction following chemically induced ER stress 
 
Procyclic form T. brucei were grown to log phase growth at 28°C without CO2 in SDM-
79 medium, and bloodstream form T. brucei were grown to log phase growth at 37°C 
with 5% CO2 in HMI9-T medium. Cells were either treated with 0.8 µg/ml tunicamycin 
or DMSO as a solvent control for 2 hr at 37°C for BSF or 28°C for PCF T. brucei. 
Polysomes were prepared as described above, with the exception that 2% NOG was 
used in the lysis buffer. In a separate experiment, cells were treated with 4 mM DTT for 
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1 hr at 37°C for BSF or 28°C for PCF T. brucei, and polysomes were prepared as 
described above. 
 
Table 2.12: qRT-PCR primers 
Preparation of cDNA libraries for RNA-seq 
Total RNA, subpolysomal, and polyribosomal RNA was isolated from BSF and PCF T. 
brucei followed by poly(A) mRNA enrichment. Three methods of mRNA enrichment 
were tested: streptavidin poly-T oligo-attached magnetic beads (Dynabeads, Invitrogen), 
poly-T oligo-attached magnetic beads (Illumina), and Terminator 5´-Phosphate-
Dependent Exonuclease (Epicentre). The mRNA was then fragmented into 200 nt 
fragments using Covaris Adaptive Focused Acoustics process. Operating conditions - 
sample volume: 130 µl, duty cycle: 10%, intensity: 5, cycles per burst: 200, processing 
time: 60 s, water bath temperature: 4°C, power mode: frequency sweeping, degassing 
mode: continuous. Fragmented mRNA was concentrated by ethanol precipitation and 
measured on a RNA Pico chip (Agilent 2100 Bioanalyzer). All enzymes and buffer 
Gene Name qRT-PCR Forward Primer  qRT-PCR Reverse Primer 
TbTransketolase AAG GCT TCG GTG CCT CTG CG AAT GGG ACC GCT TCG CTG GC 
TbAconitase CGC GGC TGC TGT ACT ATC GGG ACT CGC CCA GCC AGG GCA TA 
TbmMDH AGC TGC CCG GTG GAA CTT GG CGA AGG CAA AAC CTG CTG CGA 
TbCap5.5 CTG CAG CTG AAG AAG TGC CCG T CCT GCG GCT GCG GTA CGT C 
TbRab18  GGT TCC GGA CGC TCA CCA GC CGC CTC CTC CAC CCC ATC CA 
TbDPMS CTG CGC GCA CTG TAG GCG AGA GAG TAG AAC CGT GAG CGC GGT G 
TbBiP CTA CCC ATG CGG ACA ACC CAG CAG GAG GAA TTC CCG AC 
TbGlucosidase GTC ATT CTC GGG TAC GAA GG GGT TCC GCA GTA CAA GGG AC 
TbCalreticulin GAT GGA CCC AGC TGA ACT C GTA ACT TGG GCG CTT CTT CC 
TbPDI GGT CAA GCC TAA TGA AAC TGC CAC CGA AGT CCC TCC AAA CC 
TbUGGT CTG GAG GTA AGG CTG ACG GAG TCG CAT GGT TTG C 
TbGAPDH TCG TGA TGG GCG TGA ACC AC GTG GAG ATG CCG AAG CCC TC 
TbEnolase AGG ATG CTG TGA ACG TTG GT TCC ATG CAG ATG GCG AAC TT 
TbTrypanothione 
Reductase 
TGC AGA CTT CGC ATG GAC CG GCA GAC TCG CGA AGG TGG TC 
TbPRP GAA GTT GAA GGT GTT GTG AGT CC CCT CCA GCG TGA TAT CTG TTA CC 
TbTERT GAG CGT GTG ACT TCC GAA GG AGG AAC TGT CAC GGA GTT TGC 
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purchased from NEB. The first strand of cDNA was synthesized using reverse 
transcriptase and random primers, followed by second strand cDNA synthesis which 
removes the RNA template producing double-stranded cDNA. To blunt-end the DNA 
fragments, an end repair reaction was performed with Klenow polymerase, T4 DNA 
polymerase, and T4 polynucleotide kinase. A single 3´ adenosine overhang was added 
to the cDNA allowing the ligation of Illumina adaptors. These adaptors contain primer 
sites both for sequencing and complimentary annealing onto the Illumina flow cell 
surface. Adaptor ligated cDNA fragments were measured on an Agilent DNA chip. The 
final cDNA library was sequenced on a MiSeq Personal Sequencer of HiSeq2000 
(Illumina). Following sequencing, alignment and quantitation were performed using the 
following workflow: 
Bioinformatic analysis of RNA-seq data (Bernardo Foth/Michele Tinti) 
MiSeq RNA-sequencing: Sequence reads were mapped to the 927 reference genome 
using Tophat and filtered for minimum mapping quality (-q 30) and to softclip the 
shorter half of mappings when a read is mapped across an intron. Sequence reads per 
exon were counted using BEDtools(annotation provided as GFF file). Next, the total 
read count per gene was calculated by summing up the reads over all exons belonging to 
the same gene. Differential expression analysis was done using the R module edgeR. 
adjusted p value (adj.P.Val) indicates how significantly differentially "expressed" a 
particular gene in a particular pairwise comparison is. The adjusted read counts 
"pseudocounts" per gene following normalisation, give a feel for the reproducibility 
between the biological replicates and for absolute transcript levels per gene.  
High-Seq RNA sequencing analysis was conducted using the same pipeline as above 
with the following amendments. Differential analysis done with edgeR with adjusted p-
value < 1e-10. A different statistical model (GLM = generalized linear model) was used 
44 
 
within the previously used software package edgeR, which considers "all data at once" 
(as opposed to only considering the data for a given pairwise comparison at a time).  
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RESULTS – CHAPTER I 
3. Essentiality of the mRNA capping enzymes 
3.1 Generation of TbCMT1 conditional null mutants and investigation of their 
phenotype 
For all cells in which it has been investigated, the presence of the 5´RNA cap is vital for 
cell viability, effective gene expression, and mRNA stability. However, the question of 
cap essentiality remains unanswered in bloodstream form T. brucei. Cap formation 
occurs in three steps: first, the 5´ triphosphate group on RNA is hydrolysed by a 
triphosphatase to produce diphosphate–RNA. Next, the guanylyltransferase catalyses 
the addition of GMP to the diphosphate–RNA to produce the guanosine cap. Finally, the 
cap is acted upon by a guanine-7-methyltransferase, catalysing the methylation of the 
guanosine cap at the N-7 position. In addition to the three capping enzymes described, 
trypanosomatids have an additional guanylyltransferase and methyltransferase in the 
form of a bifunctional enzyme (Takagi et al., 2007).The significance of the bifunctional 
capping enzyme remains unclear, so we propose to compare the essentiality of this 
bifunctional enzyme (TbCGM1) with the monomeric methyltransferase (TbCMT1) in 
BSF T. brucei. 
All conditional null mutants were generated in the T. brucei Lister 427 bloodstream 
form cell line which has been genetically modified to express the tet repressor protein 
(TetR) and T7 RNA polymerase under the selection of neomycin and is therefore 
known as single marker (SM) (Wirtz et al., 1999). Using this cell line, conditional null 
mutants were created by sequential allelic replacement with antibiotic resistance 
cassettes by homologous recombination.  In case of the gene of interest is essential for 
the parasite’s viability, an ectopic copy of the gene was introduced after replacement of 
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the first allele. The ectopic copy is incorporated into the rDNA locus by homologous 
recombination using a tetracycline inducible promoter to drive expression of the gene.  
A schematic of the strategy used to construct TbCMT1 gene replacement plasmids is 
shown in (Figure 3.1). Upstream and downstream TbCMT1 UTRs were first amplified 
by PCR and sequenced to ensure sequence differences between the TritrypDB annotated 
T. brucei 927 strain and the laboratory T. brucei 427 strain did not interfere with primer 
design. About 500 bp of 5´ and 3´ UTRs containing the necessary restriction enzyme 
sites were amplified and then joined together by PCR via a pre-determined 
complimentary sequence. The 5´ forward and 3´ reverse primers were then used to 
amplify the single piece of DNA containing both UTRs and cloned into the pGEM5Zf 
vector. An antibiotic resistance cassette was then introduced in place of the 
complementary sequence, and the resulting plasmid was sequenced to confirm correct 
amplification and insertion. The final knockout construct was released from the vector 
with NotI digestion and it was then ready for transfection.    
 
 
Figure 3.1: Strategy for the generation of gene replacement constructs.  
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Homologous recombination, targeted to the 5´ and 3´UTRs described above, allowed 
the first and second alleles of the TbCMT1 gene to be replaced with PAC and HYG 
resistance cassettes, respectively. Given the possibility that the gene might be essential 
in vitro, before the second allele was replaced, a tetracycline-inducible ectopic copy of 
the TbCMT1 gene in the plew100 vector was introduced and induced to maintain 
cellular protein levels during the second round of allelic gene replacement (Figure 3.2). 
The genotypes of the recovered cells were analyzed by Southern blot, showing the loss 
of the endogenous TbCMT1 alleles and appearance of the ectopic TbCMT1 copy in the 
conditional null mutant (Figure 3.3, panel A).  These Southern blots also confirmed the 
antibiotic resistance cassettes were in the correct loci (Figure 3.3, panels B and C). 
When Wirtz and colleagues generated the SM cell line described above, a fragment of 
the hygromycin gene used to target the TetR construct remained in the genome. 
Consequently, an additional band was present at about 1.3 kb band on the Southern blot 
probed with HYG (Figure 3.3, panel C). 
To assess the phenotype of the TbCMT1 conditional null mutant, cell growth rate was 
observed under permissive (+tet) and non-permissive (-tet) conditions over 10 days 
(Figure 3.4). After 24h in non-permissive conditions, less than 1% of TbCMT1 
transcript was detected compared with cells grown permissive conditions (Figure 3.4, 
panel A). The growth curve for the mutants showed that non-permissive conditions did 
not substantially impair the growth of the cells, indicating TbCMT1 is dispensable for T. 
brucei survival in vitro (Figure 3.4, panel B).    
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Figure 3.2: Bloodstream form T. brucei TbCMT1 gene replacement strategy. (A) 
Cartoon representing the arrangement of human and T. brucei mRNA capping 
enzymes, red box outlines monomeric methyltransferase enzyme TbCMT1. (B) The 
first allele of TbCMT1 was replaced with a PAC resistance cassette. An ectopic copy 
of a tetracycline-inducible version of TbCMT1 with three C-terminal c-myc tags was 
introduced into the rDNA locus using a procyclin promoter under the control of two 
tet-operator (TetO) sequences. Selection was via a phleomycin (PHLEO) resistance 
marker driven by a T7 promoter. Activation of the ectopic copy with tetracycline 
allows replacement of the second allele, regardless of essentiality, with a HYG 
resistance cassette. 
A 
B  
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Figure 3.3: Southern blot analysis of the bloodstream form TbCMT1 conditional null 
mutant. Genomic DNA was extracted from parental SM (TbCMT1
+/+
) cells  
(lane 1), cells with one TbCMT1 allele replaced with PAC and an ectopic tetracycline 
inducible copy of TbCMT1 introduced (TbCMT1
-/+
, TbCMT1
Ti
) (lane 2), and the same 
cells following replacement of the second TbCMT1 allele with HYG  
(TbCMT1
-/-
, TbCMT1
Ti
) (lane 3). The DNA was digested with restriction enzymes 
PstI and XhoI. The maps show the predicted gDNA fragment sizes for CMT1 and for 
the correct replacement of the antibiotic resistance genes. The Southern blots were 
probed with A: CMT1 ORF, B: PAC, C: HYG. Note the weakly hybridizing band to 
the HYG probe in lanes 1 and 2 is due to the fragment of the hygromycin gene in the 
SM cell line.  
A 
B
C
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Figure 3.4: TbCMT1 is not essential for bloodstream form cell growth in vitro. (A) 
Total RNA cells grown in non-permissive conditions for 48 hours was purified 
and analysed by qRT-PCR to analyse the downregulation of TbCMT1 transcript. 
Three biological replicates were analysed; the mean ± standard deviations are 
shown. Results were normalized to the constitutive gene: telomerase reverse 
transcriptase (TERT) (Brenndörfer and Boshart, 2010). (B) Growth curve of 
TbCMT1 cKO cells grown in permissive (+ tet) and non-permissive (- tet) 
conditions. TbCMT1 conditional null mutants (+/- tet) were grown in parallel; 
cultures were counted every 24 h and diluted to 1x10
5
 cells/ml every two days. 
Three biological replicates were counted in triplicate; the mean ± standard 
deviations are shown.  
A 
B 
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3.2 Generation of TbCMT1 null mutants 
As further and final validation that TbCMT1 is not essential for parasite survival in 
culture, a TbCMT1 null mutant (without an ectopic copy) was created. The TbCMT1 
single allele replacement (TbCMT1
-/+
) cells described above were electroporated and 
the second allele replaced with a HYG resistance cassette. Recovered cells were 
analysed by Southern blot and the disappearance of the 528 bp band corresponds to the 
TbCMT1 ORF in lane 3 (Figure 3.5, panel A) and the presence of the PAC and HYG 
genes in the correct loci, indicated by the presence of the 2 kb and 1.1 and 1.3 kb bands 
in lane 3, respectively, confirmed the generation of the TbCMT1 null mutant (Figure 
3.5, panel B and C).  As described in section 3.1, an additional band is seen in the blot 
probed with HYG (at 1.3 kb) due to the residual fragment of the gene in the gDNA of 
the T. brucei SM cell line (Figure 3.5, panel C).  
3.3 Investigation of TbCMT1 null mutant phenotype 
To assess the viability of TbCMT1 null mutants, the cell growth rate was observed in 
comparison with single marker cells over 10 days (Figure 3.6). The growth curve for the 
mutants showed that the absence of TbCMT1 did not substantially impair the growth 
rate of the cells, confirming TbCMT1 is not essential for T. brucei survival in vitro. 
From these results, we decided to investigate whether TbCMT1 influences T. brucei 
parasitemia in animal infections. Three groups of mice were compared in the study: 
single marker cells as a positive control for the infection, TbCMT1 null mutant cells, 
and TbCMT1 conditional null mutant cells. For the week prior and throughout the 
course of the infection, doxycycline was added to the drinking water of the mice 
infected with the TbCMT1 conditional null mutant to induce expression of the ectopic 
copy.  
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Figure 3.5: Southern blot analysis of the bloodstream form TbCMT1 null mutant. 
Genomic DNA was extracted from parental SM (TbCMT1
+/+
) cells (lane 1), cells with 
one TbCMT1 allele replaced with PAC (TbCMT1
-/+
) (lane 2), and the same cells 
following replacement of the second TbCMT1 allele with HYG (TbCMT1
-/-
) (lane 3). 
The DNA was digested with restriction enzymes PstI and XhoI. The maps show the 
predicted gDNA fragment sizes for CMT1 and for the correct replacement of the 
antibiotic resistance genes. The Southern blots were probed with A: CMT1 ORF,  
B: PAC, C: HYG. Note the weakly hybridizing band to the HYG probe in lanes 1 and 
2 is due to the fragment of the hygromycin gene in the SM cell line.  
A 
B  
C  
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Figure 3.6: TbCMT1 is not essential for bloodstream form cell growth in vitro. 
Growth curve of TbCMT1 null mutant (dKO) cells. SM and TbCMT1 null mutants 
were grown in parallel;cultures were counted every 24 h and diluted to 5x10
4
 cells/ml 
every two days. Three biological replicates were counted in triplicate; the mean  
± standard deviations are shown.  
Figure 3.7: TbCMT1 is important for T. brucei virulence in vivo. Mice were infected 
with SM, TbCMT1 null (dKO), and TbCMT1 conditional null (cKO) cell lines and 
blood parasitemias were measured after 3 days of infection. TbCMT1 cKO mice were 
dosed with doxycycline for 7 days before and throughout the infection. Ten animals 
(nine for SM) were counted in triplicate, the mean ± standard error are shown. 
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The SM cell lines grew well, as expected, but the parasitemia in TbCMT1 null infected 
mice was very low. In the presence of the doxycycline induced ectopic copy, the 
infection was as high as SM cells suggesting the decrease in parasitemia was a direct 
result of the absence of TbCMT1 (Figure 3.7).  
Trypanosomes predominantly regulate gene expression post-transcriptionally; therefore, 
we decided to investigate the effect of the absence of TbCMT1 on translation using 
polysome profiling. Cell lysates from cultured single marker and TbCMT1 null mutant 
cells were fractionated on sucrose gradients (10-50%) in order to compare the actively 
translated mRNAs between cell lines. The polysomal material was equally abundant in 
single marker and TbCMT1 null mutant cells. Although it is possible that the 
distribution of certain transcripts within the polysomal pool is different between the cell 
lines, an overall translation defect was not seen in TbCMT1 null mutant cells  
(Figure 3.8).   
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Figure 3.8: Analysis of the ribosome distribution in single marker and TbCMT1 null 
T. brucei. Polysome profiles of (A) single marker (SM) and (B) TbCMT1 null mutant 
(dKO) cells. Absorbance at 254 nm, an indicator of RNA abundance, (y axis) is 
plotted against the sucrose gradient fractions (x axis). The positions of free ribosomal 
subunits and polysomes are indicated. Polysomal fractions 8-11 are unresolved due to 
the RNA abundance in the samples reaching the limit the absorbance detection range 
of the gradient fraction collector. 
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3.4 RNA-seq analysis of SM and TbCMT1 null mutants 
To gain more insight into the mechanisms underlying the decreased virulence of 
TbCMT1 null mutants, we performed RNA-seq on SM and TbCMT1 null mutant (dKO) 
cell lines. Four biological and two technical replicates were sequenced using an 
IlluminaMiSeq sequencer. A high correlation for the read counts of biological replicates 
for SM (average Pearson correlation coefficient R = 0.938) and TbCMT1 dKO 
(average R=0.97) T. brucei confirmed the reproducibility of the methodology (Figure 
3.9). The differential expression of genes affected by the loss of TbCMT1 was evaluated 
using three different statistical approaches and the common hits of all three were used 
for further analysis (Figure 3.10). The MA plot visualizes the relationship between 
intensity and the differences between the two data sets.  We detected 29 significantly 
differentially expressed genes which exhibited a 2-fold or greater change (P<0.05) 
(Table 3.1). Of these genes, 21 genes (72%) were downregulated in TbCMT1 null cells 
compared to SM control and 8 genes (28%) were upregulated. Of the downregulated 
genes, the majority, 11 genes (52%) belong to the cysteine peptidase family of proteins. 
Other observed categories of differentially expressed genes include VSG and expression 
site associated genes (ESAGs), and novel coding sequences that are as yet unannotated 
in the genome. Although at first glance it appeared that TbCMT1 was the only third 
most downregulated transcript in the dataset, upon closer analysis, the RNA-seq 
coverage plot revealed the sequence reads assigned to gene were from the 5´ and 3´ 
UTRs. None of the reads were detected from the ORF, confirming the generation of a 
TbCMT1 null cell line (Figure 3.11).  
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Figure 3.9: RNA-seqbiological replicate analysis. Matrices of pairwise scatter plots 
of the correlation between log10normalized read counts between two biological 
replicates of (A) single marker (SM) and (B) TbCMT1 null (dKO) T. brucei samples. 
Pairwise Pearson correlation values (Pr) are displayed above each plot. Graph 
generated by Michele Tinti, MAJF lab. 
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Figure 3.10: MA plot of RNA-seq dataset. An MA plot creates a visual 
representation of differentially expressed genes identified in SM and TbCMT1 null 
(dKO)T. brucei cell lines. Data represent individual gene responses derived from 
DEseq differential expression analysis plotted as average intensity vs the log2 fold-
change (p-values <0.05). A negative fold change represents down-regulated genes 
and a positive fold change represents up-regulated genes. Red points designate genes 
that were found to be significantly differentially expressed in all three processing 
algorithms. Graph generated by Michele Tinti, MAJF lab. 
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Table 3.1: Summary 
of RNA-seq results. 
Genes with a 
minimum 2 fold 
change in expression 
between SM and 
TbCMT1 null (dKO)  
T. brucei cell 
lines(p-values 
<0.05). VSG and 
expression site 
associated genes 
(ESAG) are 
highlighted in blue, 
cysteine peptidases 
are highlighted in 
green, and genes 
with unannotated 
coding sequences 
(CDS) are 
highlighted in 
purple. The new 
CDS failed to reveal 
any conserved 
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Figure 3.11: RNA-seq coverage plots for TbCMT1 mRNAs. The number of sequence 
reads on the y-axis is shown along the length of the TbCMT1 gene in the four 
biological replicates of the SM (SM1-4) and TbCMT1 null (dKO) T. brucei cell lines 
(dKO1-4). Schematic of the transcript shows the coding sequence (black) and UTRs 
(grey). Plot generated by Michele Tinti, MAJF lab. 
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3.5 Essentiality of the bifunctional guanylyltransferase-methyltransferase TbCGM1 
 
Despite several attempts, it was not possible to generate conditional null mutants of 
TbCGM1 (Figure 3.12, panel A). Although cells recovered after electroporation, initial 
attempts to replace the first allele with the PAC resistance cassette failed due to 
insertion of the cassette into incorrect loci. In case of haploinsufficiency, the TbCGM1 
ectopic copy was electroporated into the cells before replacement of the first allele. 
Indeed, with the ectopic copy present, the first allele was successfully replaced. 
However, the tetracycline regulation of the ectopic copy was lost and as a result it was 
expressed constitutively (data not shown). This further suggested the possibility that 
bloodstream form T. brucei were haploinsufficient for TbCGM1. An alternative ectopic 
copy expression vector (pLew100 v5) with higher tet-induced expression was 
introduced to maintain higher levels of TbCGM1 during allele replacement (Figure 
3.12, panel B). Western blot analysis of recovered cells showed tet-induced expression 
of the HA-tagged protein with no detectable expression in un-induced cells (Figure 
3.13). Nonetheless, replacement of the first allele with the PAC resistance cassette was 
unsuccessful and once again the cassette was introduced into the wrong locus. Finally, 
the first allele was replaced with the HYG resistance cassette, but when the TbCGM1
-/+
, 
TbCGM1
Ti
 cells were cultured in non-permissive conditions the growth rate was not 
impaired, disproving the previous hypothesis that the cells are haploinsufficient for 
TbCGM1. Attempts to replace the second allele with the PAC resistance cassette were 
yet again met with misincorporation of the construct (data not shown). 
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Figure 3.12: Bloodstream form T. brucei TbCGM1 gene replacement strategy (A) 
Cartoon representing the arrangement of human and T. brucei mRNA capping 
enzymes, red box outlines bifunctional enzymeTbCGM1. (B) The first allele of 
TbCGM1was replaced with a HYG resistance cassette. An ectopic copy of a 
tetracycline-inducible version of TbCGM1 with three C-terminal HA tags was 
introduced into the rDNA locus using a rRNA promoter under the control of two tet-
operator (TetO) sequences. Selection was via a phleomycin (PHLEO) resistance 
marker driven by a T7 promoter and suppressed by two T7 terminators. Activation of 
the ectopic copy with tetracycline should allow replacement of the second allele, 
regardless of essentiality, with a PAC resistance cassette. 
A  
B  
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Figure 3.13: Western blot analysis of bloodstream form T. brucei expressing a3 HA-
tagged TbCGM1 ectopic copy. Cell lysate (1x10
7
 cells/lane) of SM, and cells 
expressing TbCGM1-3HA with the pLew100v5 vector grown in permissive (+ tet) and 
non-permissive (- tet) conditions were resolved by SDS-PAGE, blotted on 
nitrocellulose, and probed with anti-HA antibody. The membrane was stained with 
Ponceau before blocking to verify equal protein loading in each well.  
64 
 
3.6 Essentiality of TbCGM1 by RNAi knockdown  
 
Following the inconclusiveness of essentiality by gene replacement, inducible RNA 
interference (RNAi) was used in bloodstream form T. brucei. A 535 bp fragment of the 
TbCGM1 ORF was cloned into a pRPa
iSL
 stem-loop RNAi vector. The resulting 
construct was electroporated into 2T1 T. brucei cells to generate a cell line expressing a 
tetracycline inducible double-stranded RNA (dsRNA) targeting TbCGM1. Correct 
integration of the construct into the rRNA spacer was assayed first by hygromycin 
selection followed by a check for puromycin sensitivity. Activation of the dsRNA 
targeting TbCGM1 resulted in 67 ± 17% knockdown of TbCGM1 mRNA after 24 h 
(Figure 3.14, panel A). TbCGM1 knockdown resulted in reduction of the growth rate 
after 24 h that led to cell death after 48 h, demonstrating the essentiality of TbCGM1 in 
culture (Figure 3.14, panel B).  
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Figure 3.14: TbCGM1 is essential for bloodstream form cell growth in vitro. (A) 
Total RNA from cells that were uninduced or tetracycline induced to knockdown 
TbCGM1 for 24 hours was purified and analysed by qRT-PCR to analyse the 
downregulation of TbCGM1 transcript. Three biological replicates were analysed; 
the mean ± standard deviations are shown. Results were normalized to the 
constitutive gene: telomerase reverse transcriptase (TERT) (Brenndörfer and 
Boshart, 2010). (B) Growth curve of cells that were uninduced or tetracycline 
induced to knockdown TbCGM1with gene specific RNAi. Cells were grown in 
parallel; cultures were counted every 24 h and diluted to 1x10
5 
cells/ml every day. 
Induced cells were treated with 1µg/ml tetracycline every day. Three biological 
replicates were counted in triplicate; the mean ± standard deviations are shown.  
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RESULTS – CHAPTER II  
4. Structural investigation of the T. brucei mRNA 5´ cap 
4.1 Theoretical products of trifluoroacetic acid hydrolysis 
The mRNA 5´ cap is required for to transport the transcript from the nucleus to the 
cytoplasm, maintain mRNA stability and allow for the efficient translation the transcript 
to protein. To investigate the possibility that some of the mRNA 5´ cap nucleosides in 
T. brucei are structurally different from conventional 7-methylguanosine, a method was 
developed to isolate the cap from endogenous mRNA and analyse the resulting structure 
by mass spectrometry.  The possibility of novel mRNA cap structure(s) was suggested 
by the existence of an additional guanylyltransferase/methyltransferase (TbCGM1) 
found in kinetoplastids but is absent in other eukaryotes. The structure of the typical 
eukaryotic mRNA methyl cap is an inverted guanosine residue methylated at the 
nitrogen 7 position. The 7-methylguanosine cap is joined to the first transcribed 
nucleotide by a 5´-5´ triphosphate linkage (Figure 4.1). This linkage is different from 
the 5´-3´phosphodiester bonds which join the rest of the nucleotides in an RNA 
molecule. To explore the chemical properties of the cap, we used the commercially 
available analogue m7GpppG. This analogue mimics the 5´end of an mRNA transcript 
with 7-methylguanosine connected to a guanosine (representing the first nucleotide) via 
a triphosphate bridge (Figure 4.2). In T. brucei, the first nucleotide of the splice leader 
sequence is a tri-methylated adenosine (Bangs et al., 1992). However, for the purpose of 
developing the mRNA cap isolation method, the guanosine in the analogue was deemed 
to be acceptable.  
Trifluororacetic acid (TFA) is an acid that lends itself to the hydrolysis of biopolymers 
and its volatility expedites removal of the reagent before the subsequent steps of any 
protocol. The first step of the method was to use mild acid (TFA) hydrolysis to exploit 
68 
 
the extreme acid lability of pyrophosphate bonds (relative to 5´ or 
3´phosphodiesterbonds). In a cell, polyphosphate (including pyrophosphate) bonds are 
hydrolysed by enzymes and in the absence of enzymatic catalysis their hydrolysis is 
very slow, except in under acidic conditions (Huebner and Milburn, 1980; Van Wazer et 
al., 1955). We made use of this principle to differentiate between the triphosphate bond 
linking the 5´ cap to the transcript, and all of the other bonds connecting individual 
nucleotides in a transcript (Figure 4.1). The theoretical products of the TFA hydrolysis 
of the methyl cap analogue m7GpppG are shown in Figure 4.3.  A time course of the 
TFA hydrolysis of m7GpppG was performed and the products of the reaction were 
resolved by thin layer chromatography (TLC). A range of standards were used to 
compare the results of hydrolysis with the theoretical reaction products (Figure 4.4). 
Unfortunately, the products generated by TFA hydrolysis of m7GpppG were more 
complex than expected and consequently all further analysis was carried out using 
negative ion electrospray mass spectrometry.  
4.2 Optimization of TFA hydrolysis 
A mixture of the potential products of TFA hydrolysis was resolved by mass 
spectrometry (Figure 4.5). The differences in mass between the compounds yielded 
clear distinction between the standards. Next, the hypothesis that TFA will 
predominantly cleave adjacent phosphate bonds and not disturb the ribose sugar-base 
portion of the cap structure was investigated by hydrolysing components of the cap 
analogue as well as theoretical hydrolysis products (Figure 4.6). As predicted, TFA does 
not hydrolyse guanosine (Figure 4.6, panel A), or guanosine monophosphate (GMP) 
(Figure 4.6, panel B). 
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Figure 4.1: Structure of mRNA 5’ cap. The mRNA 5’cap structure is composed of 
a 7-methylguanosine linked to the body of the mRNA transcript through a 5’-5’ 
triphosphate bridge. The N7 methylation of the guanosine is outlined in red. 
Figure 4.2: mRNA cap structure analogue. 7-methylguanosine linked to a guanosine 
through a 5’-5’ triphosphate bridge.       = 7-methylguanosine,  
     = guanosine, P = phosphate group.   
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Figure 4.3: Theoretical products of TFA hydrolysed cap structure analogue, 
m7GpppG. Predicted sites for hydrolysis are designated by the dotted red lines. 
Cleavage between the α and β phosphate groups would yield products A (m7GMP) 
and B (GDP); cleavage between the β and γ phosphate groups would yield products 
C (m7GDP) and D (GMP); and cleavage of both possible sites would yield products 
A and C.  
Figure 4.4: TFA hydrolysis time course of cap structure analogue, m7GpppG. Six 
standards: (guanosine (G), 7-methylguanosine (m7G), guanosine monophosphate 
(GMP), cyclic GMP (cGMP), guanosine diphosphate (GDP), and guanosine 
triphosphate (GTP) and the starting material: m7GpppG were resolved by TLC 
alongside the products of TFA hydrolysis with increased time.  
A B 
DC 
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7-methylguanosine could not be analysed because the methylation at the N7 position 
confers a positive charge to the cap structure and our analysis was carried out using the 
negative ion mode of the mass spectrometer. However, in the subsequent experiments 
described below, the cap structure was analysed in the form m7GDP which was readily 
detected. When hydrolysed with TFA, the pyrophosphate bond in guanosine 
diphosphate (GDP) yielded GMP (Figure 4.6, panel C) and guanosine triphosphate 
(GTP) yielded GDP and GMP as anticipated (Figure 4.6, panel D). The hydrolysis of 
GDP and GTP also generates the degradation product ribose 5-diphosphate but the 
amount of degradation is relatively small and should not interfere with the methodology 
(Figure 4.6, panels C and D). Taken together these results confirm TFA primarily 
hydrolyses pyrophosphate bonds and is therefore a reasonable choice of mild acid to 
release the majority of the cap while leaving most of the RNA intact.  
4.3 TFA hydrolysis of cap analogue m7GpppG 
Hydrolysis conditions were optimized to obtain the greatest yield of m7GDP (Figure 
4.3, “product C”). Following confirmation that the starting material (m7GpppG) was 
pure (Figure 4.7, panel A), as a first approximation, the cap analogue was hydrolysed 
for 15 min (Figure 4.7, panel B). Evidence of both the starting material and desired 
reaction product (m7GDP) indicated 15 min is in the range of optimal hydrolysis. Next, 
a TFA hydrolysis time course was performed where time points were collected between 
0 and 20 min (Figure 4.8). The 0 min time point served as a positive control for the 
stability of the starting material in the absence of acid (Figure 4.8, panel A). m7GDP 
was undetectable before 5 min of hydrolysis (Figure 4.8, panel B), very little was 
detected before 15 min (Figure 4.8, panels C and D), and the greatest yield of m7G was 
found after 20 min of TFA hydrolysis (Figure 4.8, panel F). More than 20 min of 
hydrolysis resulted in a greater proportion of the ribose-5-diphosphate degradation 
product than m7GDP (data not shown).   
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Figure 4.5: Chemical standards of theoretical hydrolysis products. Representative 
negative ion ES-MS chromatogram of a mixture of cap analogues (GpppG and 
m7GpppG) and the potential products of TFA hydrolysis (G, cGMP, and GMP). 
Figure 4.6: (next page) TFA hydrolysis of theoretical reaction products. 
Representative negative ion ES-MS chromatograms of standards of G, GMP, GDP, 
and GTP hydrolysed with TFA. (A/B) The majority of G and GMP were not 
hydrolysed as seen by the [M-H]
-
  ions at m/z 282 and m/z 362, respectively. (C) 
GDP observed as the [M-H]
-
 ion at m/z 442 is hydrolysed into GMP seen by the [M-
H]
-
 ion at m/z 362 and the degradation product ribose diphosphate at m/z 309. (D) 
GTP is completely hydrolysed into GDP and GMP detected as the [M-H]
-
 ions at m/z 
442 and 362, respectively. The degradation product ribose diphosphate was also 
observed at m/z 309. Data collected on Ultima.The presence of sodium adduct ions  
[M-2H+Na
+
]
-
 are indicated. 
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Figure 4.7: TFA hydrolysis of m7GpppG. (A) Representative ES-MS chromatogram 
of the starting material, cap analogue m7GpppG, was observed as the major  
[M-2H]
2-
 ion at m/z 400 and as the [M-H]
-
 ion at m/z 801. (B) TFA hydrolysis of 
m7GpppG shows non-hydrolysed starting material at m/z 400. Two diphosphate 
containing products are detected: the GDP ion at m/z 442 and the m7GDP ion at m/z 
456. Side products GMP and m7GMP were detected at m/z 362 and m/z 376, 
respectively, as well as a ribose diphosphate degradation product at m/z 309.  
Data collected on Ultima. 
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4.4 Precursor ion scanning mass spectrometry 
Each nucleotide in an RNA molecule is connected to the adjacent nucleotide by a 
phosphate group. The exception to this arrangement is the 5´cap, which is connected to 
the first nucleotide by three phosphate groups as described above. This exception can be 
exploited by TFA hydrolysis because the cap is the only structure in mRNA that can be 
released with a pyrophosphate group. In precursor ion scanning mass spectrometry, the 
specific loss of an ion (in this case pyrophosphate) from the precursor molecule is 
monitored across the spectrum. Having optimized hydrolysis conditions that obtain the 
greatest yield of m7GDP, a precursor ion scanning method was established to detect 
nucleoside diphosphates (Figure 4.9).  
Figure 4.8: Time course of the TFA hydrolysis of m7GpppG. Time points were 
collected between 2 and 20 minutes. The two diphosphate containing products: the 
GDP ion at m/z 442 and the m7GDP ion at m/z 456 are detected with increasing 
intensity over the course of 20 m. Data collected on Ultima. 
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To achieve this, negative ion mass spectrometry was performed on an authentic 
standard of GDP, which produces an intense [M-H]
 -
 ion at m/z 442 (Figure 4.10, panel 
A). This ion was then selected in MS1, collision induced dissociation (CID) was 
performed in the hexapole collision cell, and the product ions in MS2 were detected. As 
expected, one of these product ions arises from the elimination of the pyrophosphate 
group (Figure 4.10, panel B). The mass spectrometer was then set up in precursor ion 
scanning mode to search for precursors of the m/z 159 pyrophosphate ions. In this 
mode, the spectrum will only be of ions that produce an m/z 159 product ion. This 
highly selective filter enables the identification of pyrophosphate containing molecules 
amongst a complex mixture and therefore potential novel cap structures of any mass can 
be identified. The method will not be able to discriminate isobaric cap structures; 
however, differences in HPLC retention time and/or product ion MS/MS experiments of 
ions derived from mRNA, for example, m/z 456 ions should provide evidence of novel 
isobaric structures.  
4.5 TFA hydrolysis coupled to precursor ion scanning mass spectrometry of m7GpppG 
A trial precursor ion spectrum using GDP with the pyrophosphate precursor ion 
scanning mode yielded a strong m/z 442 precursor ion, as expected (Figure 4.10, panel 
C). TFA hydrolysis and the precursor ion scanning method were combined and tested 
on the cap analogue m7GpppG. Encouragingly, both predicted precursor ions were 
observed: the GDP ion at m/z 442 and the m7GDP ion at m/z 456 (Figure 4.11). Despite 
a predicted equal ratio of GDP to m7GDP after hydrolysis, the intensity of GDP in the 
spectrum appears approximately three times greater because the fixed positive charge 
on the N7 nitrogen of m7GDP reduces its ionizability in the negative ion mode of the 
mass spectrometer. Nonetheless, qualitatively, the m7GDP peak observed at m/z 456 
indicated that this ion was effectively cleaved from the cap analogue by TFA hydrolysis 
and detected by precursor ion mass spectrometry.  
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Figure 4.9: The principle of precursor ion scanning mass spectrometry. Ions pass 
through the first analyser (MS1) and then undergo collision-induced dissociation 
(CID) in the collision cell. The resulting fragments are analysed by the second 
analyser (MS2). Precursor ion scanning sets the MS2 analyser to select only one 
specific fragment ion (in this case the pyrophosphate ion m/z 159) to transmit to the 
detector. MS1 is then scanned to detect all of the precursor ions that generate this 
fragment. 
Figure 4.10: (next page) Precursor ion scanning method. (A) MS1 spectrum of the 
GDP standard (                   ) confirmed by the m/z 442 ion consistent with [M-H]
-
 
species. Data collected on QTRAP 4000. (B) MS/MS spectrum of the product ions 
of m/z 442, including the pyrophosphate ion (m/z 159). Data collected on Ultima. (C) 
Precursor ion scan of m/z 159 produced an intense peak for predicted ion m/z 442 
corresponding to GDP. Data collected on QTRAP 4000. 
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Figure 4.11: Precursor ion scan of TFA hydrolysed m7GpppG. Spectrum of the 
pyrophosphate ion (m/z 159) precursor ion scan produced intense peaks for the 
predicted pyrophosphate containing product ions: GDP ion at m/z 442 the m7GDP 
ion at m/z 456. Non-hydrolysed starting material (m/z 400) and ribose diphosphate 
(m/z 309) are also detected. Data collected on QTRAP 4000. 
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4.6 Mass spectrometer sensitivity optimization 
The method was then ready to analyse in vitro transcribed RNA to gauge sensitivity 
with transcripts. Several preparations of in vitro transcribed RNA were prepared, but 
neither GDP nor m7GDP precursor ions could be detected (data not shown). The 
m7GDP ions cleaved off of the in vitro transcript may have been below the limit of 
detection of the mass spectrometer because the quantity of hydrolysed cap was less 
certain than in the experiments with the cap analogue. To address this, titrations of the 
GDP standard were used as a surrogate for the cap structure to optimize the sensitivity 
of the mass spectrometer. An intense peak of the GDP [M-H]
-
 ion at m/z 442 was 
achieved at 10 pmol, a significant improvement on the initial sensitivity of 1 nmol 
(Figure 4.12). With this improved sensitivity, the method was tested on mammalian 
HEK-293 cell total RNA (data not shown). Although the precursor ion scanning method 
is a very selective filter, the complexity of cell culture derived RNA revealed that the 
signal to noise ratio in the spectrum was too low to observe the 5´ cap diphosphate ion 
m7GDP. Increasing the amount of input RNA would not improve the spectrum as the 
number of unidentifiable precursor ions would also increase proportionally. To purify 
the sample prior to hydrolysis and analysis, the mRNA was selectively enriched out of 
the mixture of tRNA and highly abundant rRNA.  
4.7 Poly(A) mRNA binding buffer optimization 
In addition to the 5´ cap, mRNA is characteristically polyadenylated on its 3´ end. This 
polyadenylated region can be used to efficiently recover mRNA from the other RNA 
molecules using oligo-dT cellulose. In order to use this technique in conjunction with 
mass spectrometry, it was necessary to identify a suitable substitute for the oligo-dT 
buffers because salts and detergents cannot be used in mass spectrometers and further 
purification may cause sample loss. Salts overload the system with charged salt ions and 
generate multiple salt adducts of the desired analyte.  
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Therefore, components of the oligo-dT cellulose binding buffer were methodically 
removed and replaced with salts that can be better tolerated by the system. To explore 
the effects of binding buffer modification on mRNA extraction, total RNA from HEK-
293 cells was enriched for mRNA using five different buffers. The positive control for 
effective mRNA purification was the standard binding buffer (Figure 4.13, panel A). 
Alone, the removal of the detergent sodium dodecyl sulphate (SDS) or the decrease in 
ethylenediaminetetraacetic acid (EDTA) concentration resulted in residual 
rRNAobserved in the three characteristic rRNA peaks(Figure 4.13, panels B and D). 
The removal of and SDS, Tris(hydroxymethyl)aminomethane (Tris) and substitution of 
sodium chloride (NaCl) with sodium acetate (NaOAc) reduced the mRNA binding 
capacity of the oligo-dT cellulose resulting in a lower yield, though the purified mRNA 
did not contain residual rRNA (Figure 4.13, panel C). Further alteration of the buffer by 
additionally decreasing the EDTA concentration proved unsuccessful with both a low 
yield and residual rRNA (Figure 4.13, panel E). Buffer number three was chosen for 
mRNA purification because it gave the purest yield and was incorporated into 
subsequent experiments (Figure 4.13, panel C).  
Figure 4.12: Precursor ion scan of GDP standard. Spectrum of the pyrophosphate ion 
(m/z 159) precursor ion scan of 10 pmol of pure GDP produced an intense peak for 
the predicted pyrophosphate containing GDP ion at m/z 442. Data collected on 
QTRAP 4000. 
82 
 
 
83 
 
 
Figure 4.13: Modification of the oligo-dT binding buffer for mass spectrometry. 
Bioanalyzerelectropherograms of T. brucei mRNA purified using oligo-dT cellulose 
with variable binding buffers. (A) the standard binding buffer: 0.5M NaCl, 1mM 
EDTA, 10mM Tris, 0.05% SDS, (B) the standard buffer without SDS: 0.5M NaCl, 
1mM EDTA, 10mM Tris, (C) the standard buffer without SDS, Tris, and NaCl: 
0.5M NaOAc, 1mM EDTA, (D) the standard buffer with a lower concentration of 
EDTA: 0.5M NaCl, 1µM EDTA, 10mM Tris, 0.05% SDS, (E) the standard buffer 
without SDS, Tris, NaCl, and with a lower concentration of EDTA : 0.5M NaOAc,  
1µM EDTA. Peak at 25 nt indicates fluorescence standard. nt= nucleotides,  
FU= Fluorescence Units 
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4.8 TFA hydrolysis method trial with HEK-293 cell mRNA 
Combing these improvements, the method was re-designed (Figure 4.14). HEK-293 
cells were used to assess the complete method from the culture flask to the precursor ion 
scan (Figure 4.15). An extracted ion chromatogram (XIC) filters the spectra to display a 
particular precursor ion. The XIC for the m7GDP ion at m/z 456 showed a peak at 15.89 
m (Figure 4.15, panels A and B). This peak had only marginally greater intensity than 
the adjacent unknown peak at 21.16 m. However, the elution time of the m7GDP ion 
corresponded to the elution time of the m7GDP ion generated by hydrolysis of the cap 
analogue. The XIC of the unmethylated cap, GDP ion at m/z 442 produced an intense 
peak at 20.35 m (Figure 4.15, panels C and D). Ions tentatively corresponding to ADP 
at m/z 426 and CDP at m/z 402 were also detected. However, their identity has not been 
confirmed with an authentic standard. The intensity of the GDP peak was unexpected as 
the majority of the mRNA cap is thought to be a methylated (Rottman et al., 1974).  
Taken together, there is evidence that at least a proportion the mammalian mRNA cap is 
7-methylguanosine. 
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Figure 4.14: Schematic of TFA hydrolysis of mRNA. Red dashed lines indicate 
predicted cleavage of the molecule upon treatment with TFA and boxed product 
indicates m7GDP ion. Following hydrolysis, precursor ion mass spectrometry 
method was developed to identify the 5’cap structure which yielded a pyrophosphate 
molecule upon collision induced dissociation.  
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Figure 4.15:(previous pages) Precursor ion scan of TFA hydrolysed HEK-293 cell 
mRNA. Spectrum of the pyrophosphate ion (m/z 159) precursor ion scan produced 
peaks of the predicted pyrophosphate containing precursor ions. (A) Extracted ion 
chromatogram (XIC) of pyrophosphate precursor ion at m/z 456. (B) The peak 
observed at 15.89 m was identified as the m7GDP [M-H]
-
 ion. (C) XIC of 
pyrophosphate precursor ion at m/z 442. (D) The peak observed at 20.35 m was 
identified as the GDP [M-H]
-
 ion. The CDP [M-H]
-
 ion at m/z 402 and ADP [M-H]
-
 
ion at m/z 426 were also detected. Data collected on QTRAP 4000. 
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RESULTS – CHAPTER III 
5. Comparative transcriptomics and proteomics of T. brucei polysomal 
mRNA 
5.1 Preparation of polysomal RNA 
Previous transcriptome analyses using RNA-seq on laboratory cultured T. brucei found 
that gene expression is predominantly controlled post-transcriptionally (Kolev et al., 
2010; Nilsson et al., 2010; Siegel et al., 2010). Consequently, the significant changes in 
protein levels observed between life cycle stages cannot be accounted for using 
transcript abundance alone(Urbaniak et al., 2012, 2013). Given this disparity between 
transcript and protein ratios, our hypothesis was that mRNA recruitment to ribosomes 
might contribute to the regulation of gene expression in T. brucei. To test this 
hypothesis, polysome profile analysis was used to monitor the efficiency of translation 
between bloodstream form and procyclic form T. brucei. More than one 80S ribosomal 
monosome subunit can be translating an mRNA transcript at a time producing so called 
‘polysomes’ (Mašek et al., 2011). The number of ribosomes on an mRNA generally 
reflects that transcripts translatability under given conditions (Spirin, 1999). Further, a 
particular mRNA’s higher or lower than average association with ribosomes indicates 
potential involvement of gene-specific regulatory mechanisms (Pradet-Balade et al., 
2001). Because translation is a highly dynamic process, cells were treated with the 
antibiotic cycloheximide to prevent polysome run-off during sample preparation. 
Cycloheximide binds to the 60S ribosomal subunit and arrests translation elongation by 
inhibiting release of the deacylatedtRNA from the ribosome E site, thereby stalling the 
ribosomes on mRNA in a polysomal state (Obrig et al., 1971; Stöcklein and 
Piepersberg, 1980).  
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The high protein content of polysomes allows them to be separated throughout a sucrose 
gradient according to the number of ribosomes attached to the mRNA (Figure 5.1).  
Free ribosomal subunits and mRNA that is not associated with ribosomes fractionate at 
the top of the gradient and are known as ‘subpolysomes’, while polysomes contain 
transcripts that are associated with at least one ribosome and fractionate in the second 
half of the gradient. The RNA content and separation of subpolysomes from polysomes 
across the gradient was monitored by UV absorbance at 254 nm. Following polysome 
profiling, RNA purified either from individual fractions or pooled polysomal fractions 
was used for qRT-PCR and RNA-seq analysis (Figure 5.1).  
5.2 Polysome profile distributions of developmentally regulated genes 
To investigate the relative translation between BSF and PCF T. brucei, cell lysates of 
the two life stages were subjected to polysome gradient fractionation. Equal numbers of 
cells were treated with cycloheximide, and the clarified lysate was resolved through a 
sucrose gradient. While both BSF and PCF appeared to be highly translating cells 
(indicated by there being a greater proportion of RNA in the polysomal fraction of the 
gradient) PCF cells showed a substantially greater ratio of polysomal to subpolysomal 
RNA (Figure 5.2). A group of five genes were selected to investigate their translational 
efficiency on the basis that the difference in their protein expression levels between the 
two life cycle stages is greater than the observed difference in transcript levels. To 
understand if ribosome association or segregation plays a role in the regulation of 
protein expression, the distribution of the transcripts for the genes was analysed across 
the polysome profile using qRT-PCR.  
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Dolicholphosphate mannose synthase (DPMS) was chosen as a control gene because its 
function in the formation of the trimannoside core structure of the GPI anchor and the 
Man9GlcNAc2-P-P-dolichol precursor of protein N-glycosylation exists in both life 
cycle stages of T. brucei(Mazhari-Tabrizi et al., 1996).As predicted, the distribution of 
DPMS mRNA was predominantly in the polysomal fraction of the gradient which 
indicated that was a highly translated transcript in both bloodstream and procyclic form 
T. brucei (Figure 5.3, panel A).RAB18, a GTPase that is important for the processing of 
surface proteins for vesicle trafficking in the Golgi complex. It has only been observed 
Figure 5.1: Schematic of cell lysate resolution through a sucrose gradient. 
Representative absorbance trace of a BSF polysome profile during collection of 
fractions.The first seven fractions contain subpolysomes and the last four fractions 
contain polysomes.Free monosomes (80S) and ribosomal subunits (40S and 60S) are 
indicated with arrows. Representative bioanalyserelectropherogram of purified RNA 
from the gradient depicting the three characteristic rRNA peaks. The baseline of 
polysome profile was normalized to the absorbance of a blank gradient. 
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in BSF at the protein level, but there is RNA detected in the PCF (Jeffries et al., 2002). 
Although RAB18 had a greater proportion of its transcripts in the BSF polysome 
fraction relative to the PCF polysome fraction (Figure 5.3, panel B), the effect was not 
profound and is unlikely to account for the BSF-specific nature of RAB18 protein 
expression.  
 
 
 
 
Transketolase, a component of the pentose phosphate pathway, is involved in the 
generation of ribose 5-phosphate for nucleotide biosynthesis and NADPH for defence 
against oxidative stress. This procyclic form specific protein is undetectable in BSF 
lysate both by Western blot and in TbTKT enzymatic assays (Stoffel et al., 2011). 
Although significantly reduced in comparison with PCF, TbTKT transcript was detected 
in BSF cells by Northern blot suggesting the difference in transcript level may be 
smaller than protein level (Stoffel et al., 2011). Consistent with those results, there was 
more TbTKT mRNA observed in the PCF polysomal fractions relative to BSF while the 
Figure 5.2: Polysome profiles of two different T. brucei life cycle stages. 
Representative absorbance (254 nm) trace of polysome profiles post fractionation 
comparing BSF and PCF.   
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opposite was seen in the subpolysomal fraction (Figure 5.3, panel C). Aconitase is a 
protein responsible for the conversion of citrate to isocitrate in the Kreb’s cycle. It has 
been shown to be a developmentally regulated gene that is only expressed in the stumpy 
and procyclic forms. At the RNA level, there is little difference between the life cycle 
stages suggesting the mechanism of regulation is translational or post-translational 
(Saas et al., 2000). When analysed by polysome profile, although the procyclic form 
distribution was ambiguous, there appeared to be more polysomal mRNA in 
bloodstream form than procyclic form (Figure 5.3, panel D). Another procyclic form 
specific Kreb’s cycle protein, mitochondrial malate dehydrogenase (mMDH), functions 
in aspartate metabolism by reducing oxaloacetate to malate and enabling the transfer of 
reducing equivalents (such as NADH) from the cytosol to the mitochondrion (Anderson 
et al., 1998; Aranda et al., 2006). Similar to the profile obtained for TbTKT, there was 
more TbmMDH mRNA observed in the PCF polysomal fractions relative to BSF 
polysomal fractions of the polysome profile (Figure 5.3, panel E). A cytoskeletal 
calpain-related protein CAP5.5 that is essential for correct procyclic form 
morphogenesis was not detectable in bloodstream form cells while expression of 
CAP5.5 gave evidence for only 5-fold difference in mRNA (Hertz-Fowler et al., 2001; 
Olego-Fernandez et al., 2009). Polysome profile analysis also showed an increase in 
polysome associated transcript in PCF compared to BSF (Figure 5.3, panel F).  
In order to further analyse the varying distribution of these six gene transcripts across a 
polysome profile, RNA purified from BSF and PCF pooled subpolysomal and 
polysomal fractions was transcribed into cDNA and analysed by qRT-PCR using gene-
specific primers. TbRAB18, TbTKT, TbmMDH, and TbTCAP5.5 all confirmed their 
respective enrichment in polysome-derived material although (except for TbTKT) the 
increase was not substantial (Figure 5.4). The control gene, TbDPMS, showed a slight 
enrichment in PCF polysomes, while TbAconitaseshowed a slight enrichment in BSF 
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polysomes, contradicting the results in Figure 5.3. The data for this small number of 
transcripts appeared mostly promising, however it would be difficult to establish trends 
for larger subsets of genes based on these methods and therefore a genome-wide 
approach using RNA-seq was pursued.  
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Figure 5.3: Transcript distribution across polysome profiles of bloodstream and 
procyclic form T. brucei. Total RNA was purified from each fraction of two 
polysome profiles comparing BSF and PCF.  qRT-PCR was performed on six 
transcripts using gene-specific primers: (A) dolicholphosphate mannose synthase 
(DPMS), (B) RAB18, (C) transketolase, (D) aconitase, (E) mitochondrial malate 
dehydrogenase (mMDH), and (F) CAP5.5 to analyse their distribution across the 
sucrose gradient. Genes with the greatest amount of transcript in the later fractions 
indicates polysome association.  
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5.3 cDNA library preparation for Illumina sequencing 
To prepare samples for RNA-seq, cDNA libraries were generated from both total 
mRNA and polysome-associated mRNA transcripts. Due to the high proportion of 
rRNA in a cell (>90%), it was depleted from the sample using oligo-dT beads which 
enrich for polyadenylated mRNA. The removal of rRNA is essential to maximize 
coverage of low abundance transcripts from the number of reads possible per machine 
run. Three possible mRNA enrichment strategies were tried: Illuminaoligo-dT beads, 
Dynaoligo-dT beads, and treatment with Terminator 5´-Phosphate-Dependent 
Exonuclease. The Illuminaoligo-dT bead method produced the most consistent results 
and was the method of choice for subsequent cDNA library preparation (data not 
shown).  
Figure 5.4: Polysomal enrichment ofmRNAs.Total RNA from pooled subpolysomal 
and polysomal fractions was purified and analysed by qRT-PCR for six candidate 
genes: dolicholphosphate mannose synthase (DPMS), RAB18, transketolase, 
aconitase, mitochondrial malate dehydrogenase (mMDH), and CAP5.5 to analyse 
their relative abundance in the polysomal fraction. Three biological replicates were 
analysed; the mean ± standard deviations are shown. 
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Following purification, the mRNA was sheared into smaller fragments for optimal 
sequencing coverage of smaller transcripts and to circumvent the potential bias of 
reverse transcriptase. Ultrasonic fragmentation conditions were optimized to produce 
~200 nucleotide sections to maximize coverage of the sequencer’s paired-end reads 
(data not shown). The fragmented mRNA was then reverse transcribed into cDNA. 
Double stranded cDNA was then end repaired, and a terminal dA nucleotide was added 
to prime for the adaptor ligation, resulting in the final cDNA library to be sequenced 
(Figure 5.5). It is important to note that unlike the established cDNA library protocol, 
our procedure enabled the library to be completed without PCR amplification, therefore 
eliminating the sample bias associated with variable amplification. Throughout the 
cDNA library preparation procedure, samples were monitored by Agilent Bioanalyser to 
ensure RNA integrity and cDNA quantity (Figure 5.6). 
Figure 5.5: cDNA library preparation method. Schematic of the process of cDNA 
library generation: total RNA extracted from T. brucei cells is enriched for mRNA, 
fragmented and transcribed into DNA with a reverse transcriptase enzyme. Bar-
coded adaptors are ligated to the double stranded cDNA to produce the final library 
to be sequenced. 
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Figure 5.6: Representative Bioanalyzerelectropherograms of cDNA libraries 
prepared for Illumina sequencing from T. brucei total and polysome associated 
RNA.RNA size in nucleotides (nt) is depicted on the x-axis and fluorescence units 
(FU) on the y-axis. The peak visible at 25 nt corresponds to the RNA/DNA sample 
dye. 
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5.4 RNA-seq of whole-cell mRNA and polysome associated mRNA in bloodstream and 
procyclic form T. brucei 
In collaboration with the Wellcome Trust Sanger Institute, eight libraries (2 biological 
replicates of BSF and PCF polysomal and total (whole-cell) derived mRNA) were 
constructed for a preliminary RNA-seq experiment to begin to investigate the 
hypothesis that mRNA selection by ribosomes might contribute to the regulation of 
gene expression.Using next-generation sequencing (IlluminaMiSeq), we obtained 16.6 
million high-quality reads (8.3 million read-pairs) for the first technical replicate and 
18.2 million high-quality reads (9.1 million read pairs) for the second technical 
replicate. A high correlation for the read counts of biological and technical replicates 
(average Pearson correlation coefficient R = 0.967) confirmed the reproducibility of 
the methodology (Figure 5.7, panels A and B). Scatter plots of the correlations between 
the log of Reads Per Kilobase of exon model per Million mapped reads (RPKM) values 
for the two biological replicates of the two conditions examined in this experiment 
(whole cell mRNA (WC) and polysome associated mRNA (pol)) also depicted the 
differences between bloodstream and procyclic form samples as well as between total 
mRNA and polysomal mRNA samples. For low RPKM values, (lower left corner of 
graphs) the slight pear-shape was to be expected due to the increase in errors for low 
read signals (Figure 5.7, panel A). The differences of the mRNA populations in the 
samples analysed were appreciated by the numbers of significantly differentially 
expressed transcripts (< p=0.00001) (Figure 5.7, panel C). The biggest difference in 
gene expression was between bloodstream and procyclic form total mRNA (805 
transcripts). Bloodstream and procyclic polysomal mRNA also revealed a similar 
number of translational changes (755 transcripts). Within each life cycle stage, fewer 
genes were seen with changes between total mRNA and polysomal mRNA (BSF: 241 
transcripts, PCF: 144 transcripts).  
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Figure 5.7: RNA-seq analysis. (A) Matrix of pairwise scatter plots of the correlation 
between log Reads Per Kilobase of exon model per Million mapped reads(RPKM) 
values between two biological replicates of two conditions (whole cell (WC) mRNA 
and polysomal (pol) mRNA). (B) Table of pairwise Pearson correlation values for 
comparisons in panel A. (C) Table of significantly differentially expressed   
(< p=0.00001) transcripts between two life cycle stages (BSF, PCF) and two 
conditions (whole cell mRNA, polysomal mRNA). Graphs and tables generated by 
Bernardo Foth, Sanger Institute.  
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Encouraged by the reproducibility of the replicates and potentially interesting 
differences between mRNA populations, a larger RNA-seq experiment was pursued.   
5.5 Comparative transcriptomics by RNA-seq of total, subpolysomal, and 
polyribosomal poly (A+) RNA purified from bloodstream form and procyclic form  
T. brucei 
Following the preliminary experiment described above, three biological and three 
technical replicates of total, subpolysomal, and polysomal mRNA were sequenced using 
an Illumina High-Seq 2000 sequencer. The three technical replicates showed nearly 
perfect reproducibility and were therefore merged for each biological replicate. The 
reproducibility of the biological replicates was also deemed reliable. Four different 
analysis pipelines confirmed that there were hundreds of genes that were significantly 
differentially expressed and the overlap between the sets of genes generated by these 
different analyses was well over 90%. The Pearson correlations were calculated 
between the ~8400 data points in pairwise comparison to assess concordance within the 
sample replicates, yielding an average 99% correlation (Table 5.2). There were between 
1182 and 4501 significantly differentially expressed/polysome-associated genes in all 
possible pairwise sample comparisons (Table 5.1). The smallest number of 
differentially expressed genes (1182) was between the BSF and PCF subpolysome 
samples; while the largest number of differentially expressed genes (4501) was between 
the BSF whole cell and BSF subpolysome samples.  
Such large numbers of genes and the complexity of biological networks make clustering 
a useful precursory technique for analysing gene expression data. Principle component 
analysis (PCA) was used to visualize the interrelationships between the different RNA-
seq samples (Figure 5.8). The PCA confirmed the very high reproducibility of the 
technical replicates and showed the concern over sample procyclic form subpolysomal 
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replicate #3 (PCFsub-3) because it showed the most variation in its biological replicates.  
Further enquiry was necessary to understand the source of the outliers (Figure 5.8). In 
PCFsub-3, there were 375 genes for which the normalized read count deviated by more 
than 1.5-fold from the average of the other 2 replicates (PCFsub-1 and PCFsub-2). Of 
these genes, 95 were contaminant RNAs (76x snoRNAs, 19x ribosomal RNAs) and 151 
of the genes were of unknown function (annotated as hypothetical in tritryp genome 
database). Slight variation in the efficiency with which RNAs other than mRNAs are 
excluded during cDNA library preparation would easily show up in such comparisons 
between replicate samples. The PCFsub-3 sample was compared to a sample where the 
biological replicates appeared to be very close together (PCFpol) and altogether, the 
number of outlier genes in PCFsub-3 was only moderately increased compared to other 
biological samples. Therefore, PCFsub-3 was included in all analyses with adjusted 
p-value<1
-10
stringency. 
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Table 5.1: Numbers of significantly differentially expressed/polysome-associated 
genes. Pairwise comparison of the six conditions studied (total, subpolysomal and 
polysomal mRNA from BSF and PCF T. brucei). Reads were mapped to the 
reference genome using SMALT software and differential expression analysis was 
completed using DESeq software. Analysis performed by Bernardo Foth, Sanger 
Institute.  
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Figure 5.8: Principle component analysis (PCA) of RNA-seq data set. PCA of the 
RPKM values between three biological and three technical replicates of six 
conditions: total, subpolysomal and polysomal mRNA from BSF and PCF T. brucei. 
Clusters of the data from each of the six conditions are outlined with circles. The 
axes of the graph are arbitrary units of the principle components used to perform the 
analysis. Graph generated by Bernardo Foth, Sanger Institute.  
Table 5.2: Pearson correlations of the RNA-seq biological replicates. Pairwise 
comparisons between the ~8400 data points were used to calculate the corresponding 
Pearson correlations expressed as a percentage. Correlations generated by Bernardo 
Foth, Sanger Institute.  
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5.6 Comparison of RNA-seq total and polysome associated transcript levels between 
bloodstream and procyclic form T. brucei 
The data set was then used to address the question as to whether translational efficiency 
might be regulated in a life cycle-specific manner. To this end, the BSF:PCFlog-fold 
changes of normalized read counts for total mRNA were compared to those for 
polysome associated mRNA.This revealed a strong positive correlation (Pearson 
correlation coefficient = 0.95) (Figure 5.9) suggesting that the majority of transcripts are 
similarly distributed between the total mRNA and polysomal mRNA fractions. 
Examining the differential expression of total mRNA between the life stages, we 
observed the greatest up-regulation of procyclin transcripts in procyclic form and VSGs 
and glucose transporter 1B (THT1) transcripts in bloodstream form (Figure 5.10, panel 
A).  Similarly, the greatest differences in polysome associated transcripts were observed 
in procyclins for procyclic form and VSGs and THT1 for bloodstream form (Figure 
5.10, panels C). Analysis of the translational efficiency of transcripts within individual 
life stages showed that the most polysome-associated transcripts in bloodstream form 
were for the proteolysis pathway and translation machinery (ribosomal mRNA) and the 
most abundant transcripts in the total mRNA fraction were in fact contaminating rRNAs 
(Figure 5.11, panel A). Unexpectedly, in procyclic form, no transcripts showed 
enrichment in the polysomal fraction relative to the total mRNA fraction and the most 
abundant transcripts in total mRNA were also contaminating rRNA (Figure 5.11, B).  
These results suggested translational efficiency does not significantly contribute to the 
regulation of gene expression in T. brucei. 
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Figure 5.9: Scatter plot showing the comparison of normalized log fold changes. The 
log fold changes between BSF and PCF polysome associated transcripts (pol) was 
compared to the log fold changes of whole cell derived total mRNA (WC). Pearson 
correlation=0.95 Thecolored gradient denotes the log10 of the sum of the p-values for 
each correlation pair (i.e. pink correlation points represent the highest significance). 
Graph generated by Michele Tinti, MAJF lab. 
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Figure 5.10:Volcano plots of (A) whole cell derived (WC) mRNA and (C) 
polysomal (pol) mRNA in bloodstream versus procyclic form T. brucei. The 
horizontal axis is the log
2
 fold change between the life cycle stages. The -log
10
 (P-
value) is on the vertical axis. Each transcript is represented by one point on the 
graph. Points with positive values on the horizontal axis are up-regulated in 
bloodstream form and points with negative values are up-regulated in procyclic 
form. Red points highlight genes with > 4 fold differences in transcript abundance 
(p<0.05). (B) Gene ontology (GO) term analysis of pathways whose components 
exhibited elevated expression in BSF whole cell mRNA. Graphs generated by 
Michele Tinti, MAJF lab. 
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Figure 5.11 (previous page): Volcano plots of (A) bloodstream form and (B) procyclic 
form T. brucei whole cell derived (WC) mRNA versus polysomal (pol) mRNA. The 
horizontal axis is the log
2
 fold change between WC and pol transcripts. The -log
10
 (P-
value) is on the vertical axis. The absolute expression value (RPKM) for each transcript 
is represented by one point on the graph.rRNA contaminants are designated in green 
and genes involved in the ER quality control pathway are designated as red diamonds. 
Points with positive values on the horizontal axis are more abundant in polysome 
associated mRNA and points with negative values are more abundant in WC mRNA. 
Graph generated by Michele Tinti, MAJF lab. 
5.7 Analysis of RNA-seqdata for total, subpolysomal, and polyribosomal poly (A+) 
RNA from bloodstream form and procyclic form T. brucei 
The phosphoglycerate kinase (PGK) genes are a good example of post-transcriptionally 
controlled, developmentally regulated genes. Although they are in a tandem array and 
transcribed in a single polycistron, PGKA is expressed at a low level in both life stages, 
PGKB is only expressed in the procyclic form and PGKC is only expressed in 
bloodstream form T. brucei (Figure 5.12, panel A) (Blattner and Clayton, 1995; 
Colasante et al., 2007; Kapotas and Bellofatto, 1993). Consistent with those findings, 
PGKC transcripts were found in the whole cell (WC) and polysomal RNA fractions of 
bloodstream form cells; PGKB transcripts were found in the WC and polysomal RNA 
fractions of procyclic form cells, and PGKA transcripts were found in both bloodstream 
and procyclic form fractions, but at lower expression levels (Figure 5.12, panel B).  
Several mRNA transcripts were observed to be under-represented on polysomes: i.e. the 
level of transcript in the total mRNA sample was greater than the level of transcript in 
the polysomal fraction. This suggested that for certain genes, there may be a portion of 
transcripts that exist in the cells but are not translated. A number of proteins 
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(calreticulin, BiP (Grp78), glucosidase II, UGGT, and PDI (ERp57)) involved in the 
endoplasmic reticulum (ER) quality control pathway displayed the “polysome under-
representation” phenotype (Figure 5.13). In most eukaryotes, the ER quality control 
pathway initiates followingdeglucosylation of newly added Glc3Man9GlcNAc2 
structures by alpha-glucosidasesI and II. In the case of trypanosomes which only 
transfer Man9GlcNAc2 and Man5GlcNAc2, this inital trimming of α-Glc residues does 
not occur. Correctly folded glycoproteins proceed through the ER and to the Golgi 
apparatus (Trombetta et al., 1996). Misfolded glycoproteins, however, are glucosylated 
by the UDP-Glc:glycoproteinglucosyltransferase (UGGT). Calreticulin is a chaperone 
with a carbohydrate-binding domain that recognizes the UGGT 
monoglucosylatedglycans on the misfolded glycoproteins and forms a network with 
other ER chaperones including, BiP and PDI, that function to re-fold the glycoproteins 
correctly (Tatu, 1997; Vassilakos et al., 1998). As UGGT exclusively glucosylates 
misfolded glycoproteins, its function serves as a sensor for glycoprotein conformation 
(Sousa et al., 1992). Upon reaching theirtrue tertiary structure, the glycoproteins are 
deglucosylated by alpha-glucosidase II and are then permitted to continue to the Golgi 
apparatus. However, when processing by the folding machinery in the ER is insufficient 
to produce the native conformation of the glycoproteins, they are ultimately degraded 
by ER-associated degradation (ERAD) (Figure 5.14) (Tsai et al., 2002).   
We hypothesized that cells may use polysome recruitment of transcripts as a reserve 
mechanism for situations requiring rapid increase in protein expression, such as ER 
stress. To test this, cells were exposed to two ER stress inducing agents for an hour: 
dithiothreitol (DTT) a chemical that reduces disulphide bonds and tunicamycin, an 
inhibitor of N-linked glycosylation which is required for optimal protein folding (Back 
et al., 2005; Casero et al., 1982). 
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Figure 5.12: The PGK gene locus in T. brucei. (A) Genomic arrangement and 
schematic of post-transcriptional processing and protein abundance. (B) RNA-seq 
coverage plots of PGKA/B/C mRNA. The number of sequence reads (expressed as 
the RPKM value) is shown along the length of each gene.     
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Figure 5.13: RNA-seq coverage plots of calreticulin and glucosidase II mRNA. The 
number of sequence reads (expressed as the RPKM value) is shown along the length 
of each gene.      
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It was found that tunicamycin treatment had undetectable effects on the overall 
polysome distribution of both bloodstream and procyclic form cells. Both the dimethyl 
sulphoxide (DMSO) treated control and tunicamycin treated cells showed a typical 
polysome profile (Figure 5.15). However, treatment with DTT resulted in substantial 
reduction in global translation efficiency seen in the increased subpolysomal peak and 
consequently lowered polysomal peaks in the polysome profiles of both bloodstream 
and procyclic form cells (Figure 5.16).  
A subset of mRNAs that are important for the response to the ER stresses were analysed 
for their potential to redistribute into the polysome peak to enhance their rate of 
Figure 5.14: The factors involved in the ER quality control pathway in bloodstream 
form T. brucei. Proteins in grey are components of the unfolded protein response 
(UPR) found in other eukaryotes. BiP: immunoglobulin-heavy-chain-binding protein 
(Grp78), PDI: protein disulphide isomerase (ERp57), UGGT: UDP-
Glc:glycoproteinglucosyltransferase, ERAD: ER-associated degradation. Image 
adopted from (Izquierdo et al., 2009).   
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translation without necessitating additional transcription. Based on the observation of 
polysome under-representation by RNA-seq, five ER quality control proteins were 
analysed by qRT-PCR for the translocation of transcripts into the polysomal fraction of 
RNA following DTT and tunicamycin treatment. Total RNA derived from treated or 
untreated BSF and PCF T brucei was transcribed into cDNA and analysed by qRT-PCR 
using gene-specific primers. TbBiP, TbglucosidaseII, TbUGGT, Tbcalreticulin, and 
TbPDIall showed enrichment in polysome-derived material following tunicamycin 
treatment even though (except for TbPDI) the increase was not substantial (Figure 
5.17). Following DTT treatment, the increase in the enrichment of polysomal transcript 
was even less pronounced, with the exception of TbPDI in BSF cells which showed a 
substantial shift (Figure 5.18).  
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Figure 5.15: Representative absorbance (254 nm) traces of polysome profiles post 
fractionation and comparing (A) BSF and (B) PCF T. brucei that have been treated 
either with DMSO (ctrl) or tunicamycin.   
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Figure 5.16: Representative absorbance (254 nm) traces of polysome profiles post 
fractionation comparing (A) BSF and (B) PCF T. brucei that have either been 
untreated (ctrl) or treated with DTT.   
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Figure 5.17: Polysomal enrichment of mRNAs. Total RNA from pooled polysomal 
fractions of BSF and PCF T. brucei following DMSO control (untreated) or 
tunicamycin treatment was purified and analysed by qRT-PCR for five candidate 
genes: BiP, glucosidase II, UGGT, calreticulin, and PDI to analyse their relative 
abundance in the polysomal fraction. Three biological replicates were done; the 
mean ± standard deviations are shown. Results were normalized to the constitutive 
gene: paraflagellar rod protein (PRP) (Brenndörfer and Boshart, 2010). 
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Figure 5.18: Polysomal enrichment of mRNAs. Total RNA from pooled 
subpolysomal and polysomal fractions of BSF and PCF T. brucei following control 
(untreated) or DTT treatment was purified and analysed by qRT-PCR for five 
candidate genes: BiP, glucosidase II, UGGT, calreticulin, and PDI to analyse their 
relative abundance in the polysomal fraction. Three biological replicates were done; 
the mean ± standard deviations are shown. Results were normalized to the 
constitutive gene: telomerase reverse transcriptase (TERT) (Brenndörfer and 
Boshart, 2010).  
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5.8 Comparative transcriptomics by RNA-seq of total and polyribosomal poly (A+) 
RNA purified from untreated or tunicamycin treated bloodstream form T. brucei 
In order to gain insight into the widespread effects of ER stress on the BSF 
transcriptome and translatome, we performed RNA-seq on total mRNA and polysomal 
mRNA comparing tunicamycin treated to DMSO control treated bloodstream form T. 
brucei. Two biological and two technical replicates were sequenced using an 
IlluminaMiSeq sequencer. A high correlation for the read counts of biological replicates 
(average Pearson correlation coefficient R = 0.948) confirmed the reproducibility of 
the methodology (Figure 5.19). However, scatter plots comparing the two conditions 
examined (untreated (WT) and Tunicamycin (Tun) treated cells) did not reveal any 
differences between whole cell mRNA or in polysome associated mRNA transcript 
abundance (Figure 5.20). Furthermore, during the analysis, we also observed that the 
genes involved in the ER quality control pathway, in which we previously observed the 
“polysome under-representation”, no longer displayed this phenotype in the untreated 
WT sample.  
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Figure 5.19: Scatter plot showing the comparison of biological replicates. BSF 
untreated (WT) and Tunicamycin treated (Tun) log10 of the normalized reads 
(pseudocounts) were compared between whole cell derived total mRNA (WC) and 
polysome associated (pol) transcripts for two biological replicates of RNA-seq data. 
Graph generated by Michele Tinti, MAJF lab. 
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5.9 Effect of detergent concentration on the polysomal association of transcripts 
 
Following the discrepancy in the results of the two RNA-seq experiments, the 
differences between the two experiment methodologies were narrowed down to the 
addition of DMSO to the untreated cells and the concentration of n-octyl-glucoside 
(NOG) detergent being increased from 1% to 2% in the lysis buffer. The addition of 
DMSO was discounted as the source of the discrepancy because the final concentration 
Figure 5.20: Scatter plot showing the comparison of normalized read counts. 
Correlation between untreated (WT) and Tunicamycin treated BSF T. brucei 
normalized read counts derived from (A) whole cell (WC) mRNA and (B) polysome 
associated (pol) mRNA. Genes involved in the ER quality control pathway which 
were analysed by qRT-PCR are designated as red diamonds. Graph generated by 
Michele Tinti, MAJF lab. 
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of DMSO was only 0.25%. This lead to the hypothesis that under-representation of 
transcripts in the polysomal mRNA fraction might be an artefact of detergent 
concentration. To test this, polysome association of transcripts translated by cytosolic 
ribosomes was compared with signal peptide containing transcripts translated by ER-
associated ribosomes, using a titration of NOG. BSF T. brucei lysates were prepared 
with 1-10% NOG lysis buffer and resolved through a sucrose gradient as described 
above. Polysome profile analysis did not indicate any differences in the distribution of 
ribosomal RNA across the gradient with increasing NOG concentration (Figure 5.21). 
The polysomal fractions from these polysome profiles were then pooled, purified, and 
compared to whole cell extracted transcript levels using qRT-PCR (Figure 5.22). If 1% 
NOG detergent was not enough to completely solubilize ER associated ribosomes, 
lysing the cells in higher concentrations of NOG should have increased the abundance 
of polysomal transcript, however, this was not observed (Figure 5.22, panel B).  
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Figure 5.21: Representative absorbance traces of a BSF polysome profiles during 
collection of fractions. The first seven fractions contain subpolysomes and the last 
four fractions contain polysomes.Free monosomes (80S) and ribosomal subunits 
(40S and 60S) are indicated with arrows. Representative 
bioanalyserelectropherogram of purified RNA from the gradient depicting the three 
characteristic rRNA peaks. The baseline of polysome profile was normalized to the 
absorbance of a blank gradient. 
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Figure 5.22 (previous page): Distribution of polysomal transcripts with increasing 
detergent concentration. BSF T. brucei lysed with an increasing concentration of NOG 
detergent (1-10%) and RNA from whole cells and pooled polysomal fractions was 
purified and analysed by qRT-PCR. The log2FC of polysomal transcript as a function of 
NOG concentration is shown (A) Three candidate genes that are translated by 
cytoplasmic ribosomes: typanothione reductase, enolase, GAPDH and (B) five 
candidate genes with signal peptides that are translated by ER associated ribosomes: 
BiP, calreticulin, UGGT, PDI, and glucosidase II were chosen to evaluate their relative 
abundance in the polysomal fraction. Results were normalized to the constitutive gene: 
telomerase reverse transcriptase (TERT) (Brenndörfer and Boshart, 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
130 
 
5.10 Comparing the T. brucei transcriptome and proteome 
 
In order to gain insight into the relationship between translational efficiency and protein 
abundance, the correlation between the RNA-seq data set with a stable isotope labelling 
by amino acids in cell culture (SILAC) proteomic data set was examined (Figure 5.23) 
(Urbaniak et al., 2013). Correlations were determined by comparing the Log2 FC in 
whole cell derived (WC) mRNA, polysome associated mRNA or subpolysomal mRNA 
to protein. Surprisingly, the correlation between polysome associated transcripts and 
proteins was slightly lower than the correlation between total mRNA and protein 
(Figure 5.23, panels A and B). However, the very weak correlation between 
subpolysomal transcripts and proteins conformed to our expectations (Figure 5.23, 
panel C). The lack of improvement in polysome associated transcriptome correlation 
with protein abundance suggested that contrary to our initial hypothesis, using 
polysome profiling and the described data analysis pipeline, mRNA recruitment to 
ribosomes does not significantly contribute to steady state protein levels in T. brucei.  
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Figure 5.23 (previous page): Hexagon binning histograms comparing transcriptome and 
proteome fold changes (FC). The log2 FC of PCF/BSF for (A) whole cell (WC) derived 
total mRNA transcripts, (B) polysomal mRNA transcripts and (C) subpolysomal mRNA 
transcripts were compared to the log2 FC of PCF/BSF SILAC proteome. In this 
histogram, the chart area is tessellated by a grid of hexagons and the number of points 
falling into each hexagon is plotted using a color ramp in proportion to the counts. The 
color ramp denotes the log10 of the number of points contained within the hexagon (i.e. 
dark orange points represent the most frequent correlation values). Graph generated by 
Michele Tinti, MAJF lab. 
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DISCUSSION 
6.1 TbCMT1 null and conditional null mutants 
Kinetoplastids acquire their 5´mRNA cap through the trans-splicing of a 39nt SL RNA 
containing the unique cap4 structure (Bangs et al., 1992; Mair et al., 2000b). While the 
capping enzymes which form the cap0 have been biochemically characterized, the 
question of cap essentiality remains unanswered in bloodstream form T. brucei. 
Conditional null mutants of the monomeric methyltransferase TbCMT1 with a 
tetracycline inducible ectopic copy of TbCMT1 were generated in BSF trypanosomes. 
When cell growth was observed in non-permissive (-tet) conditions, the growth rate was 
nearly equivalent to cells grown in permissive (+tet) conditions. This suggested 
TbCMT1 is not essential for parasite survival in vitro which was consistent with the 
results of TbCMT1 RNAi knockdown in PCF T. brucei(Takagi et al., 2007).  
As further and final validation that TbCMT1 is not essential for parasite survival in 
culture, we generated TbCMT1 null mutants (without an ectopic copy).  Consistent with 
the results from the conditional null mutants, the growth rate of TbCMT1 null cells did 
not display any defect, they appeared and behaved as normal. We next investigated 
whether TbCMT1 influences T. brucei parasitemia in animal infections. Infections with 
SM cell lines grew well however, intriguingly, the parasitemia in TbCMT1 null infected 
mice was very low (Figure 3.7). To understand if this in vivo effect was the direct result 
of TbCMT1 loss or an off-target effect, mice infected with TbCMT1 conditional null 
mutant cells were included in the study. The presence of doxycycline (in the drinking 
water of the mice) induced expression of the ectopic copy, and restored the growth of 
the parasites in vivo. This suggested the decrease in parasitemia observed in TbCMT1 
null infected mice was a direct result of the absence of TbCMT1. Despite significant 
decrease in parasitemia of TbCMT1 null infection compared to SM cell infection, the 
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incomplete eradication of parasites from mouse blood at the end of the 3-day study 
suggests TbCMT1 may not be an essential for infectivity, but rather a virulence factor. 
The disparity between the in vitro and in vivo results is interesting and emphasizes the 
value of examining gene function with an in vivo animal model when possible. It 
appears gene essentiality is complicated by the parasites ability to tolerate the absence 
of a protein’s function in culture only to reveal their capacity to infect is diminished in 
an animal model.  
In pursuit of understanding the cellular functions affected by TbCMT1 deletion, 
polysome profiling was used to compare translational activity between SM and 
TbCMT1 null cells. Both cell lines were equally translationally active seen in the large 
proportion of RNA in the polysomal fractions (Figure 3.8). However, polysome profiles 
only offer an overall picture of cells translation, information about which proteins have 
changed their translational efficiency cannot be detected without analyzing individual 
transcripts. It would be interesting to explore which transcripts that are translationally 
up/down regulated in response to TbCMT1 functional loss.  
To gain more insight into the mechanisms underlying the decreased virulence of 
TbCMT1 null mutants, we performed RNA-seq on SM and TbCMT1 null mutant cell 
lines. With high reproducibility of the biological replicates, we detected 29 
differentially expressed genes which exhibited a 2-fold or greater change (P<0.05) 
(Table 3.1). As RNA-seq becomes increasingly popular, several different data analysis 
processing pipelines have been developed. Here we used the most accepted differential 
expression packages (cuffdiff and DeSeq) with three different combinations of 
parameters and selected the genes that were common to all three modes of analysis for 
further study. Overall, the difference between SM and TbCMT1 dKOtranscriptomes 
was minimal; the correlations between sample conditions are indistinguishable from 
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correlations between biological replicates. When the sequencing reads were mapped to 
the genome, there were 972 reads which mapped to unannotated exons. The average 
size of these novel (potential) genes is 1980bp, a reasonable size for coding sequences. 
Although no further investigation has been carried out on these sequences, four of them 
were identified as differentially expressed in the experiment. It would be interesting to 
examine these four sequences more closely for splice sites, regulatory motifs and 
protein expression in the available proteomic datasets for insight into their function.  
Of the 21 genes which were found to be downregulated, the majority belong to the 
cysteine peptidase family (Table 3.1). Although the genomic sequences of the cysteine 
peptidases are nearly identical, making sequence mapping software distribute the reads 
arbitrarily among the 11 proteins, overall, the ‘average’ transcript abundance of this 
group of genes is downregulated in the absence of TbCMT1. The results of the in vivo 
infectivity combined with RNA-seq point to an interesting possible role for TbCMT1 in 
T. brucei because parasitic protozoa are known to have an abundance of cysteine 
peptidases that are important for survival of the parasite in mammals (Rosenthal, 1999). 
Further, studies in Leishmaniamexicana have seen cysteine peptidase deficient 
amastigotes infective in vitro but with impaired infectivity in vivo (Denise et al., 2003; 
Mottram et al., 2004). The relationship between TbCMT1 and cysteine peptidases is 
unknown, and the results require additional validation to understand the scope of 
TbCMT1 loss on the pathways involving cysteine peptidases.  
The enzymes that were expected to be affected by the absence of TbCMT1 were the 
other capping enzymes. However, neither the monomeric guanylyltransferase (TbCE1) 
not the bifunctional enzyme (TbCGM1) displayed changes in transcript abundance 
suggesting TbCMT1 does not does not coordinate its function with the other capping 
enzymes in vivo. Given the extensive heterogeneity of SAS and PAS observed through 
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RNA-seq studies in T. brucei, it would be interesting to investigate changes in SAS and 
PAS site usage in TbCMT1 null cells and explore the possibility that TbCMT1 plays a 
role in alternative trans-splicing (Kolev et al., 2010; Nilsson et al., 2010; Siegel et al., 
2010).  
6.2 TbCGM1 conditional null mutants and RNAi 
In addition to the capping enzymes characterized in other eukaryotes, trypanosomatids 
have an additional guanylyltransferase and methyltransferase in the form of a 
bifunctional enzyme (Takagi et al., 2007).The significance of the bifunctional capping 
enzyme remains unclear, so we proposed to study its essentiality and functionality BSF 
T. brucei. Despite several attempts, it was not possible to generate conditional null 
mutants of TbCGM1. When initial attempts to replace the first allele with the PAC 
resistance cassette failed, a TbCGM1 ectopic copy was introduced before replacement 
of the first allele in case of haploinsufficiency. Indeed, with the ectopic copy present, 
the first allele was successfully replaced, but the tetracycline regulation of the ectopic 
copy was lost and resulted in constitutive expression of the ectopic copy.  It was thought 
that the loss of tetracycline regulation occurred by genetic rearrangement to prevent 
expression of the tetracycline repressor protein (Roper et al., 2002). In case ectopic 
expression from the pLew100 vector was not high enough to sustain gene replacement, 
an alternative ectopic copy expression vector (pLew100 v5) with 10-fold higher tet-
induced expression was introduced. Finally, the first allele was replaced with the HYG 
resistance cassette, but when the TbCGM1
-/+
, TbCGM1
Ti
 cells were cultured in non-
permissive conditions the growth rate was not impaired, disproving the previous 
hypothesis that the cells are haploinsufficient for TbCGM1. However, attempts to 
replace the second allele with the PAC resistance cassette were yet again met with 
misincorporation of the construct.  
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Unable to answer the question of essentiality using conditional null mutants, we 
changed the strategy to knockdown TbCGM1using the inducible RNAi system (Alsford 
et al., 2005). Activation of the dsRNA targeting TbCGM1 resulted in 67 ± 17% 
knockdown of TbCGM1 mRNA after 24 h and cell death by 48 h, demonstrating the 
essentiality of TbCGM1 in culture (Figure 3.14). This result is consistent with the 
results of TbCGM1 RNAi knockdown in PCF T. brucei, although, in that case the cells 
survived considerably longer after induction (Ruan et al., 2007; Takagi et al., 2007). 
Further characterization of TbCGM1 function was not carried out in this project, but 
Takagi and colleagues demonstrated that knockdown of TbCGM1 resulted in the 
accumulation of uncapped SL RNA in PCF T. brucei. With the unique capacity for both 
guanylyltransferase and methyltransferase activity, a role for TbCGM1 in capping was 
expected and confirmed by their work.  
The monomeric methyltransferase, TbCE1, did not exhibit any effects of cell growth or 
SL RNA capping when subject to knockdown by RNAi in PCF T. brucei(Ruan et al., 
2007; Takagi et al., 2007). It is possible that the residual transcript from the knockdown 
is sufficient for cell survival in culture and a conditional null mutant would be necessary 
to validate its essentiality. Taken together, the fact that neither TbCE1 nor TbCMT1 
could rescue the growth defect of TbCGM1 knockdown suggests their roles do not 
function in the same pathways as TbCGM1.   
In the future, to study the essentiality and potential redundancy of the methyltransferase 
domain of the bifunctional enzyme TbCGM1, an RNAi ‘readout’ system will be 
established. We hypothesize that the TbCGM1-depletion-induced phenotype (cell death) 
could be rescued by the presence of a constitutively active TbCGM1 wobble mutant 
which is resistance to depletion by RNAi. Assuming this is the case, we could then 
dissect which domain of the bifunctional enzyme is essential, by introducing 
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catalytically inactive methyltransferase or guanylyltransferase wobble mutants and 
assessing parasite viability following TbCGM1depletion by RNAi. 
In summary, while there are still many unanswered questions about the specific roles of 
the modified cap nucleotides and the enzymes that catalyse their formation, we suggest 
that the mRNA 5´ cap structure is essential in BSF T. brucei and that the 
TbCGM1methyltransferase and/or guanylyltransferase catalytic domains may be a drug 
targets against kinetoplastids. 
6.3 TFA hydrolysis of mRNA cap structure analogues 
To investigate the possibility that some of the mRNA 5´ cap nucleosides in T. brucei are 
structurally different from conventional 7-methylguanosine, a method was developed to 
isolate the cap from endogenous mRNA and analyse the resulting structure by mass 
spectrometry.  The possibility of novel mRNA cap structure(s) was suggested by the 
existence of an additional guanylyltransferase/methyltransferase (TbCGM1) and the 
unusual cap4 structure that is found uniquely in kinetoplastids. Our analytical approach 
was based on the extreme acid liability of pyrophosphate bonds which allowed us to 
differentiate between the triphosphate bond linking the 5´ cap to the transcript, and all 
of the other bonds connecting individual nucleotides in a transcript (Figure 4.1). The 
initial experiments showed that it was possible to resolve the starting material from the 
theoretical hydrolysis products by mass spectrometry (Figure 4.5). Next, the specificity 
of TFA hydrolysis on pyrophosphate bonds was tested on the theoretical hydrolysis 
products, and as expected, structures which lack pyrophosphate bonds (G and GMP) are 
resistant to hydrolysis (apart from the N-glycosidic bond between the ribose and the 
base). To explore the chemical properties of the cap, the commercially available 
analogue m7GpppG which mimics the 5´RNA cap structure joined to the first 
transcribed nucleotide, was used to optimize the methodology. Initial optimization of 
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TFA hydrolysis produced robust peaks of both expected hydrolysis products (GDP and 
m7GDP) and served as a proof of principle for the use of mild acid to cleave the 5´cap 
from an RNA molecule (Figure 4.7). TFA hydrolysis also yielded an undesirable ribose-
diphosphate degradation product which resulted from the cleavage of the N-
glycosidicbond between the ribose sugar and base. The presence of this degradation 
product indicated that it was necessary to optimize TFA hydrolysis such that the yield 
of desired products was maximized but not pushed to the point of excessive 
degradation; this balance was achieved by 20 min hydrolysis.  
With the exception of the 5´ cap, which is connected to the first nucleotide by three 
phosphate groups, each nucleotide in an RNA molecule is connected to the adjacent 
nucleotide by a single phosphate group. We sought to exploit this difference by TFA 
hydrolysis because the cap is the only structure in mRNA that can be released with a 
pyrophosphate group. In precursor ion scanning mass spectrometry, the specific loss of 
an ion (in this case pyrophosphate) from the precursor molecule is monitored across the 
spectrum. This highly selective filter enables the identification of pyrophosphate 
containing molecules amongst a complex mixture and therefore potential novel cap 
structures of any mass can be identified. Combining TFA hydrolysis with the precursor 
ion scanning method, analysis of the cap analogue m7GpppG yielded both predicted 
precursor ions: [m7GDP]
-
 and [GDP]
-
 (Figure 4.11). It’s important to note that there 
would only be one predicted precursor ion, [m7GDP]
-
 in an mRNA sample because the 
first nucleotide would remain attached to the rest of the mRNA. However, because the 
cap analogue m7GpppG only has a single ‘nucleotide’ on its 3´end, TFA hydrolysis 
generated two precursor ions. Despite a predicted equal ratio of GDP to m7GDP after 
hydrolysis, the intensity of GDP in the spectrum appears greater because the 
methylation at the N7 position confers a positive charge to the cap structure, thereby 
reducing its ionization in the negative ion mode of the mass spectrometer (Figure 4.11). 
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Nonetheless, qualitatively, observation of the [m7GDP]
-
 ion indicated that m7GDP was 
effectively cleaved from the cap analogue by TFA hydrolysis and detected by precursor 
ion mass spectrometry.    
6.4 Precursor ion scanning method optimization 
The method was then taken forward for testing on in vitro transcribed RNA to bridge 
the gap between the simplicity and purity of the commercially available cap analogue 
and the complexity of cell derived RNA. Despite several attempts to generate m7G 
capped in vitro RNA, the precursor ion could not be detected. While the benefit of an in 
vitro system is the ability to quickly and easily generate large quantities of in vitro 
transcript, the amount of cleaved m7GDP could not be determined with the same 
certainty as the analogue and therefore may have been below the level of detection of 
the mass spectrometer. To optimize the sensitivity of the mass spectrometer, titration of 
a GDP standard was used as a surrogate for the cap structure. A large improvement in 
sensitivity was achieved when tributylammonium acetate (TBAA) replaced 
triethylammonium acetate (TEAA) as the ion-pairing agent. As a stronger ion-pairing 
agent, TBAA bound the cap structures with a higher affinity creating better 
chromatographic separation and controlled elution. A sensitivity of 10 pmol was 
achieved with the TBAA mobile phase buffer, a significant improvement on the initial 
sensitivity of 1 nmol.  
Encouraged by this result, the method was tested on total RNA extracted from 
mammalian HEK-293 cells. Although the precursor ion scanning method is a very 
selective filter, the complexity of the biological sample revealed that the signal to noise 
ratio of the spectra was too low to observe the mRNA 5´cap diphosphate ion, m7GDP. 
The background of precursor ions that contain an m/z 159 (pyrophosphate) fragment 
overwhelmed the potential cap derived precursor ions. Increasing the amount of input 
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RNA would not improve the spectrum as the number of unidentifiable precursor ions 
would also increase proportionally. Therefore, it was necessary to enrich the sample 
prior to hydrolysis and analysis by mass spectrometry by extracting the cap-containing 
mRNA out of the mixture of tRNA and highly abundant rRNA.  
6.5 Optimization of mRNA extraction buffer 
The poly(A) tail can be used to efficiently recover mRNA from the other RNA 
molecules using oligo-dT cellulose. In order to use this technique in conjunction with 
mass spectrometry, it was necessary to identify a suitable substitute for the standard 
oligo-dT buffers because salts and detergents cannot be used in mass spectrometers. At 
the same time, further purification to exchange the mRNA into a buffer that is 
compatible with mass spectrometry will cause sample loss. Salts overload the system 
with charged salt ions and generate multiple salt adducts of the desired analyte which 
can saturate the detector. Therefore, components of the oligo-dT cellulose binding 
buffer were methodically removed and replaced with salts that can be better tolerated by 
the system. To explore the effects of binding buffer modification on mRNA extraction, 
total RNA from HEK-293 cells was enriched for mRNA using five different buffers and 
analysed for rRNA contamination on an Agilent Bioanalyser (Figure 4.13). Detergents 
interfere with the evaporation process on the electrospray of the mass spectrometer, and 
therefore the first component removed from the olig-dT buffer was SDS which resulted 
in a less efficient oligo-dT binding buffer. Decrease in the concentration of EDTA also 
resulted in a less efficient oligo-dT binding buffer. However, removal of SDS, Tris 
together with the substitution of NaClby sodium acetate resulted in a binding buffer that 
is both effective for mRNA enrichment and compatible with mass spectrometry.  
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6.6 Assessment of optimized methodology 
Combing these improvements, the method was re-designed and HEK-293 cells were 
used to assess the complete method from the culture flask to the precursor ion scan 
(Figure 4.15). A peak at m/z 456 corresponding to m7GDP precursor ion was observed 
at the elution time previously seen for the m7GDP ion generated by hydrolysis of the 
cap analogue m7GpppG. The detection of this peak was encouraging for the progress of 
the method as it supports the seminal work of (Furuichi et al., 1975; Shatkin, 1976). 
However, the signal to noise ratio is still very low, evidenced by the unknown peak 
adjacent with nearly the same intensity as the m7GDP ion peak (Figure 4.15, panel A). 
Additionally, there appears to be a large peak corresponding to GDP ion (Figure 4.15, 
panels C and D). It is not possible to distinguish whether the GDP ion is derived from 
unmethylated mRNA cap or from the partial hydrolysis of GTP that could have been a 
contaminant of the mRNA population. In order to determine the source of the GDP ion, 
the effect of recombinant mammalian cap methyltransferase (RNMT) added to mRNA 
preparations could be examined. If treatment with RNMT increases the proportion of 
m7GDP to GDP ions, it would suggest the former explanation and it would then be 
interesting to study the quantitative distribution of capped vs methylcapped mRNA 
(Cowling and Cole, 2010). Peaks potentially corresponding to ADP and CDP were also 
detected, although appropriate standards would have to be examined to accurately 
assign their presence in the sample. The next experiment proposed is to analyse BSF T. 
brucei mRNA with this method and investigate the potential differences in their TFA 
hydrolysis products. Further optimization will be necessary to improve the signal to 
noise ratio, this could be done with time course of TFA hydrolysis using mRNA instead 
of the cap analogue to determine conditions where hydrolysis side effects are at a 
minimum. Once the method is robust it could be used to explore the cap structures of 
the TbCMT1 null cell line and other kinetoplastids.  
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Although studies on the mRNA cap structure in T. brucei using thin-layer 
chromatography (TLC) identified 7-methylguanosine as the 5´ cap structure, spots that 
could not be identified with the available standards were also detected (Freistadt et al., 
1987; Sutton and Boothroyd, 1988). Advances in the sensitivity of analytical analysis 
afforded by mass spectrometry allow us to revisit the original discoveries of mRNA cap 
structure and build upon their findings. 
6.7 Preparation of polysomal RNA 
Given the disparity in studies of changes in the transcriptome vs proteome between BSF 
and PCF T. brucei, our hypothesis was that mRNA recruitment to ribosomes might 
contribute to the regulation of gene expression (Kolev et al., 2010; Nilsson et al., 2010; 
Siegel et al., 2010; Urbaniak et al., 2012). To test this hypothesis, polysome profile 
analysis was used to monitor the distribution of polysomal transcript between 
bloodstream form and procyclic form T. brucei. Polysome profiling is based on the 
principle that the high protein content of polysomes allows them to be separated 
throughout a sucrose gradient according to the number of ribosomes attached to the 
mRNA. Further, a particular mRNA’s higher or lower than average association with 
ribosomes indicates potential involvement of gene-specific regulatory mechanisms 
(Pradet-Balade et al., 2001).  
Initial polysome profile analysis revealed that both BSF and PCF trypanosomes 
appeared to be highly translating cells, indicated by observation that the majority of 
RNA is the polysomal fraction of the gradient. PCF cells also showed a noticeably 
greater ratio of polysomal to subpolysomal RNA than BSF cells confirming the higher 
rate of translation other studies have also observed in PCF cells (Vasquez et al., 2014).  
To understand if ribosome association plays a role in the regulation of protein 
expression, the distribution of the transcripts for six candidate genes was analysed 
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across the polysome profile. All of the genes examined, with the exception of 
Aconitase, displayed a polysome profile distribution consistent with the published 
results of their life cycle specific expression (Figure 5.3). The control gene, DPMS, is 
required in abundance in both life cycle stages and therefore the majority of the 
transcript was in the polysomal RNA fractions. Although RAB18, a BSF specific 
protein, had a greater proportion of its transcripts in the BSF polysome fraction relative 
to the PCF polysome fraction, the effect was not profound and is unlikely to account for 
the BSF-specific nature of RAB18 protein expression. Transketolase, mMDH and 
CAP5.5 all clearly display a enrichment in PCF polysomal fractions which was 
expected as they have been shown to be procyclic specific genes. As a first 
approximation, the data for this small number of transcripts appeared mostly promising, 
however it would be difficult to establish trends for larger subsets of genes based on 
these methods and therefore a genome-wide approach using RNA-seq was pursued.  
6.8 cDNA library preparation and preliminary RNA-seq 
To prepare samples for RNA-seq analysis, cDNA libraries were generated from both 
total mRNA and polysome-associated mRNA transcripts. Following rRNA depletion by 
selection of poly(A) mRNA using oligo-dT magnetic beads, the mRNA was sheared 
into smaller ~200 nucleotide fragments for optimal sequencing coverage of smaller 
transcripts and to circumvent the potential bias of reverse transcriptase and to maximize 
coverage of the sequencer’s paired-end reads. In addition to the potential sequence bias 
by reverse transcriptase enzyme, RNA secondary structure compounds the sequence 
bias in the cDNA library. However, both of these potential problems were alleviated by 
fragmentation of the mRNA prior to reverse transcription (Hansen et al., 2010; 
Mortazavi et al., 2008). It is important to note that unlike the established cDNA library 
protocol, our procedure enabled the library to be completed without PCR amplification, 
therefore eliminating the sample bias associated with variable amplification. The 
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procedure for the generation of cDNA libraries has been successfully optimized such 
that the amount of library necessary for Illumina sequencing can be generated without a 
large amount of initial RNA. This enables the removal of the PCR amplification step in 
favour of more reliable relative quantification of the dataset. Throughout the cDNA 
library preparation procedure, samples were monitored by Agilent Bioanalyser to ensure 
RNA integrity and cDNA quantity (Figure 5.6). Due to the ubiquitous presence of RNA 
exonucleases, the Bioanalyser is a useful tool for real-time quality control of the 
samples as well as troubleshooting difficulties with library generation. To begin to 
investigate the hypothesis that mRNA selection might contribute to the regulation of 
gene expression, two biological replicates of BSF and PCF polysomal and total (whole-
cell) derived mRNA) were constructed for a preliminary RNA-seq experiment (Figure 
5.7). The high correlations for the read counts of the biological replicated showed 
confidence in the reproducibility of polysome profile analysis and RNA-seq sample 
preparation. A matrix of scatter plots comparing all 8 samples simultaneously visualized 
the strong correlation between biological replicates contrasted with the weaker 
correlation between total mRNA and polysomal mRNA samples due to the 
differentially expressed genes. Indeed, hundreds of differentially expressed genes were 
identified, encouraging a more thorough analysis including the subpolysomal fraction, 
additional replicates, and retrieving a deeper transcriptome by performing the 
sequencing on an IlluminaHiSeq instrument.   
6.9 RNA-seq of total, subpolysomal, and polyribosomal poly (A+) RNA purified from 
bloodstream form and procyclic form T. brucei 
Three biological and three technical replicates of total, subpolysomal, and polysomal 
mRNA were sequenced andpairwise comparisons of the biological replicates showed 
strong correlations indicating they are reliable for analysis (Table 5.2). The stark 
differences between bloodstream and procyclic form T. brucei have been studied for 
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decades and recently shown on a global transcriptomic scale. Consistent with these 
findings, our dataset also detected thousands of significantly differentially expressed 
genes between the two life cycle stages (Table 5.1). Considering the contrasting 
environments these two forms of the parasite can survive and their different systems of 
immune evasion it is reasonable that so many genes change in transcript abundance.   
The volume of data generated by genome wide studies such as RNA-seq are difficult to 
visualize because there are millions of reads and thousands of genes to analyse. To 
facilitate visualizing the relationships between samples we use software to represent the 
information in a two-dimensional format that can be easily interpreted. A principle 
component analysis (PCA) was performed to visualize the distinct groups of reads 
produced by the different samples (Figure 5.8). The PCA confirmed the reproducibility 
of the replicates with one exception, PCF-sub3. This sample contained the greatest 
deviation from other two biological replicates. Further analysis of this replicate revealed 
it had the lowest Pearson correlations with an average R= 97.7 compared to an average 
R= 99.8 for the BSF-wc samples, the best correlated replicates. There were 375 genes in 
sample PCFsub-3that are potential outliers. One possibility is that slight variation in the 
efficiency with which RNAs other than mRNAs are excluded during cDNA library 
preparation could exaggerate differences. This may have been because the 
subpolysomal fraction contained all of the free monosomes. Contaminating rRNAwould 
easily show up in such comparisons between replicate samples, however, following 
statistical analysis of the deviation caused by the potential outliers, it was decided to 
keep the PCF-sub3 sample as part of the dataset and any genes that are chosen for 
validation can be manually cross-referenced with the list outlier genes.  
We then used this data set to ask question if translational efficiency might be regulated 
in a life cycle-specific manner. The strong correlation between BSF: PCF log-fold 
changes for total and poly suggests that the distribution of transcript abundance is the 
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same between total mRNA and polysome-associated mRNA (Figure 5.9). As rapidly 
proliferating and highly translationally active cells, T. brucei appear to have few 
transcripts in the cell that are not substantially polysome associated. That is not to say 
that few transcripts maintain distinct life-cycle differences, but rather that the 
differences are observed to the same extent in both in total mRNA and polysomal 
mRNA. Consistent with other transcriptomic studies, the largest upregulation of 
transcripts in the BSF were VSG and glucose transporter 1B (THT1) and the largest 
upregulation of transcripts in the PCF were procyclins(Kolev et al., 2010; Nilsson et al., 
2010; Siegel et al., 2010). This result was expected as VSGs and procyclins are highly 
expressed in their respective life stages. Bloodstream form T. brucei are entirely 
dependent on glycolysis for energy and therefore the large increase in translation 
efficiency of the low-affinity, high capacity THT1 glucose transporter was also 
expected (Bringaud and Baltz, 1993). 
A GO term analysis was performed to identify functional categories of genes that were 
up or downregulated between the lifecycle stages (Figure 5.10, panel B). The analysis 
produced very broad results of proteins in almost every category of cellular function, 
making it difficult to draw conclusions. However, the absence of differential expression 
between total mRNA and polysomal mRNA suggest translational efficiency does not 
significantly contribute to the regulation of gene expression in T. brucei. This 
conclusion contradicts the results observed by Vasquez and colleagues (Vasquez et al., 
2014). Also interested in translational control of the gene expression in T. brucei, they 
performed ribosome profiling on BSF and PCF cells. Ribosome profiling is a higher 
resolution technique to polysome profiling, however the methodologies should produce 
similar results (Ingolia et al., 2012). Although they also describe a positive correlation 
between the translational efficiencies in the two life-cycle stages, a 117-fold range in 
translational efficiency in PCF and a 64-fold range in BSF was reported (Vasquez et al., 
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2014).  However, further analysis of the differences of sample preparation and data 
analysis would be necessary to make direct comparisons between the studies. 
Following the result of the strong correlation between total mRNA and polysomal 
mRNA, it was unexpected to find transcripts that were under-represented on polysomes: 
i.e. the level of transcript in the total mRNA sample was greater than the level of 
transcript in the polysomal fraction.Because the former result suggested very little 
mRNA is untranslated, we were intrigued by the genes that did not follow the pattern 
and noticed that these genes are involved in the ER quality control pathway. This 
observation lead to the hypothesis that trypanosomes possess a reserve capacity for 
polysome recruitment in situations requiring a rapid response, such as ER stress. Two 
different stress-inducing compounds were added to T. brucei and the effect on 
polysomal transcript distribution was analysed. When treated with tunicamyicn, an N-
linked glycosylation inhibitor, no overall change in the polysomal profile was detected 
(Figure 5.15) However, when the genes involved in the ER quality control pathway 
were analysed specifically, a small but robust increase in polysomal transcript was 
observed (Figure 5.17). In contrast, treatment with DTT resulted in a substantial shift of 
transcripts into the un-translated subpolysomal fraction. While both chemically induce 
stress, the effect of tunicamycin appears to be localized to the ER while DTT appears to 
ubiquitously affect the translatome (Figure 5.16). Analysis of the genes involved in the 
ER quality control pathway following DTT treatment showed similarly small and robust 
increases in polysomal transcript with the exception of PDI which displayed a large 
shift toward polysomal transcript (Figure 5.18). As DTT treatment disrupts disulphide 
bonds present in the cell, it might be expected for the cell to respond with a large 
increase in PDI to re-form the disordered bonds.  
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6.10 RNA-seqanalysis of tunicamycin treated vs untreated bloodstream form T. brucei 
In order to gain insight into the widespread effects of ER stress on the BSF 
transcriptome and translatome, we performed RNA-seq comparing tunicamycin treated 
to untreated bloodstream form T. brucei.Surprisingly, a comparison of thepolysomal 
association of transcripts in the presence or absence of tunicamycin did not reveal any 
differences (Figure 5.20). This suggested that contrary to the hypothesis, inducing ER 
stress in T. brucei via treatment with Tunicamycin does not promote increased 
translation of ER quality control genes by higher association with polysomes. However, 
analysis of the under-represented genes studied individually by qRT-PCR showed that 
the “polysome under-representation” phenotype was not reproducible in the untreated 
RNA-seq sample. We scrutinized the methodology to try to identify the source of the 
difference between the experiments, however only two differences emerged. First, to 
control for solvent effects, DMSO was added to the untreated BSF cells at the same 
concentration and for equal duration as tunicamycin. However, the final concentration 
of DMSO was determined to be only 0.25% and therefore deemed inconsequential. The 
second difference was the use of 2% NOG detergent instead of the 1% NOG detergent 
used in the previous RNA-seq experiments. The concentration of detergent was 
increased in the lysis buffer to be sure that all rough ER membrane bound polysomes 
were solubilized and their translating mRNA purified. This lead to the hypothesis that 
under-representation of transcripts in the polysomal mRNA fraction might be an artefact 
of detergent concentration. In the event that detergent concentration affected the 
proportion of polysomal transcript, it was though that genes containing signal peptides 
were more likely to be subject to this potential artefact. This was investigated by the 
comparison of Trypanothione reductase, enolase, and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) which are all enzymes without signal peptides and are 
therefore presumed to be translated on cytoplasmic ribosomes (Aslett et al., 2010). 
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Conversely, the genes that appeared under-represented in the polysomal fraction (BiP, 
calreticulin, UGGT, PDI, and glucosidase II) contain signal peptides are therefore 
presumed to be translated on ER associated ribosomes (Aslett et al., 2010). Using 
increasing concentration of the NOG detergent, this selected group of genes were 
analysed for their proportion of polysomal transcript. However, increasing the 
concentration of NOG did not significantly increase the proportion of polysomal 
transcript in either set of candidate genes examined (Figure 5.22). Although this 
experiment was only performed once and requires additional replicates for statistical 
significance, there was no observable trend to support the idea that polysome 
association of transcripts with signal peptides is a function of detergent concentration. 
This suggested the inconsistency of transcript under-representation on polysomes might 
not be an artefact of detergent concentration. The procedure for cell lysis does not 
appear to be standardized because while some studies performing polysome profiling 
use 1% NOG, other studies used 1% Triton X-100 and still others lysed T. brucei 
through the sonication of frozen cells or vortexing with glass beads (Capewell et al., 
2013; Djikeng et al., 2003; Smith et al., 2009; Vasquez et al., 2014). One possible 
reason for the discrepancy between the experiments is that the untreated cells were also 
under stress and therefore increased the polysomal association of stress-response 
transcripts. For future experiments it is important confirm the effectiveness of 
tunicamycin on the inhibition of glycosylation as well as to test untreated cells for the 
upregulation of stress factors to ensure the fidelity of the conclusions that will be drawn 
from the experiment.  
6.11Comparing the T. brucei transcriptome and proteome 
Following the results of this study that the majority of transcripts are similarly 
distributed between total mRNA and polysomal mRNA fractions, combined with the 
results of other transcriptomic studies which found only 5.6-32% of the transcriptome 
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changes between BSF and PCF T. brucei, we endeavoured to compare translational 
efficiency with protein abundance (Figure 5.23) (Kolev et al., 2010; Nilsson et al., 
2010; Siegel et al., 2010). Correlations between the RNA-seq data set and (SILAC) 
proteomic data revealed the correlation between polysome associated transcripts and 
proteins was in fact slightly lower than the correlation between total mRNA and protein 
(Urbaniak et al., 2013). However, the very weak correlation between subpolysomal 
transcripts and proteins conformed to our expectations. Previously described 
correlations between SILAC proteomics data and three different microarray 
transcriptomic datasets showed higher correlations with two of the studies 
(R=0.83/0.86) and significantly lower correlation with the third study (R=0.2), 
illustrating the difficulty of combining data from different genomic studies (Urbaniak et 
al., 2012). Even so, the lack of improvement in polysome associated transcriptome 
correlation with protein abundance suggeststhat our initial hypothesis that mRNA 
recruitment to ribosomes might contribute to the regulation of gene expression could 
not be supported with our experimental system.  
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